Metrics
Publication
380
Open Access
53
UN Sustainable Development Goals
Announcements & Documents
Thesis Documents
Download File
Education
1987 - 1991
1987 - 1991Expertise In Medicine
Dokuz Eylul University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Turkey
1980 - 1986
1980 - 1986Undergraduate
Ege University, Faculty Of Medicine, Turkey
Research Areas
Health Sciences
Academic Positions
1988 - Present
1988 - PresentProfessor
Dokuz Eylul University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Non Academic Experience
2009 - Present
2009 - PresentProfesör
Dokuz Eylül Üniversitesi Tıp Fakültesi Ruh Sağlığı ve Hastalıkları Anabilim Dalı, Profesör
2002 - Present
2002 - PresentProfesör
Dokuz Eylül Üniversitesi Tıp Fakültesi Psikiyatri Anabilim Dalı, Profesör
2002 - 2009
2002 - 2009Profesör
Dokuz Eylül Üniversitesi Tıp Fakültesi Psikiyatri Anabilim Dalı, Profesör
1997 - 2002
1997 - 2002Doçent
Dokuz Eylül Üniversitesi Tıp Fakültesi Psikiyatri Anabilim Dalı, Doçent
1997 - 2002
1997 - 2002Doçent
Dokuz Eylül Üniversitesi Tıp Fakültesi Psikiyatri Anabilim Dalı, Doçent
1995 - 1997
1995 - 1997Yardımcı Doçent
Dokuz Eylül Üniversitesi Tıp Fakültesi Psikiyatri Anabilim Dalı, Yardımcı Doçent
1995 - 1997
1995 - 1997Yardımcı Doçent
Dokuz Eylül Üniversitesi Tıp Fakültesi Psikiyatri Anabilim Dalı, Yardımcı Doçent
1993 - 1995
1993 - 1995Öğretim Görevlisi
Dokuz Eylül Üniversitesi Tıp Fakültesi Psikiyatri Anabilim Dalı, Öğretim Görevlisi
1993 - 1995
1993 - 1995Öğretim Görevlisi
Dokuz Eylül Üniversitesi Tıp Fakültesi Psikiyatri Anabilim Dalı, Öğretim Görevlisi
1991 - 1993
1991 - 1993UZMAN
Ünye SSK Psikiyatri Hastanesi, UZMAN
1987 - 1991
1987 - 1991Araştırma Görevlisi
Dokuz Eylül Üniversitesi Tıp Fakültesi Psikiyatri Anabilim Dalı, Araştırma Görevlisi
1987 - 1991
1987 - 1991Araştırma Görevlisi
Dokuz Eylül Üniversitesi Tıp Fakültesi Psikiyatri Anabilim Dalı, Araştırma Görevlisi
1986 - 1987
1986 - 1987Tabip
SAMSUN CARSAMBA EGERCILI SAGLIK OCAGI, Tabip
1986 - 1987
1986 - 1987Tabip
SAMSUN CARSAMBA EGERCILI SAGLIK OCAGI, Tabip
Supervised Theses
2024
2024Doctorate
Sanal Gerçeklik Uygulamasının Şizofrenide Psikososyal İşlev Bozukluğunun İyileştirilmesinde Kullanılması
Alptekin K. (Advisor)
E.Ilgın(Student)
2023
2023Postgraduate
The relationship between the level of expression of emotions of the caregivers in patients with schizophrenia and the level of thought disorder in patients with schizophrenia
Alptekin K. (Advisor)
D.GENÇASLAN(Student)
2023
2023Postgraduate
The effect of metacognitive education treatment on thought disorder and cognitive impairment in Schizophrenia patients
ALPTEKİN K. (Advisor)
S.KOYUNCUOĞLU(Student)
2022
2022Postgraduate
The effect of online meta cognition education in schizophrenia
Alptekin K. (Advisor)
S.ERİNÇ(Student)
2021
2021Doctorate
Cognitive and social cognitive impairments: A 4-year follow-up study
ALPTEKİN K. (Advisor)
B.DEĞİRMENCİOĞLU(Student)
2019
2019Doctorate
Thought disorder as a core symptom cluster of schizophrenia
ALPTEKİN K. (Advisor)
B.YALINÇETİN(Student)
2019
2019Expertise In Medicine
Reliability and validity study of schizophrenia cognition rating scale (SCORS) which assess cognitive impairment in schizophrenia patients
ALPTEKİN K. (Advisor)
N.ÖZAK(Student)
2019
2019Postgraduate
Prevelance of technological devices and internet use among patients diagnosed with schizophrenia and schizoaffective disorder
ALPTEKİN K. (Advisor)
E.ILGIN(Student)
2018
2018Expertise In Medicine
The evaluation of psychosocial functioning level of hospitalized patients at psychiatry clinic diagnosed with schizophrenia and schizophrenia spectrum disorder following 10 years
ALPTEKİN K. (Advisor)
S.SOYLU(Student)
2017
2017Postgraduate
6 Yıl Süreyle İzlenen Toplum Temelli Bir Normal Örneklemde Sosyal Sermayenin Psikoz Benzeri Yaşantıların ve Psikotik Bozuklukların Gelişmesindeki Etkisi
ALPTEKİN K. (Advisor)
K.YILDIRIM(Student)
2017
2017Postgraduate
Relation of early-onset psychosis and duration of untreated psychosis to formal thought disorder in schizophrenia
ALPTEKİN K. (Advisor)
S.ALTINOK(Student)
2016
2016Postgraduate
Relationship between smoking with theory of mind and clinical characteristics in patients with schizophrenia
ALPTEKİN K. (Advisor)
G.ATAR(Student)
2015
2015Postgraduate
Neuropsychological assessment in first episode psychosis
ALPTEKİN K. (Advisor)
E.AYDINLI(Student)
2015
2015Postgraduate
The relationship between theory of mind and structure of thoughts language in schizophrenia
ALPTEKİN K. (Co-Advisor), AKDEDE B. B. (Co-Advisor)
D.GÜNEYER(Student)
2015
2015Expertise In Medicine
Relation with corpus callosum volume and negative symptoms in first attack psychosis: Retrospective magnetic resonance imaging study
ALPTEKİN K. (Advisor)
O.AĞDANLI(Student)
2014
2014Postgraduate
The relation of thought-language disorders in schizophrenia with remission of symptoms and psychosocial improvement
ALPTEKİN K. (Co-Advisor), AKDEDE B. B. (Co-Advisor)
B.YALINÇETİN(Student)
2014
2014Expertise In Medicine
The effect of antipsychotic drugs on thought-language disorder in schizophrenia
ALPTEKİN K. (Advisor)
L.VAR(Student)
2010
2010Expertise In Medicine
Thought disorder in patients with schizophrenia and their unaffected siblings and relations with family functions
ALPTEKİN K. (Advisor)
S.POLAT(Student)
2008
2008Postgraduate
The relation between theory of mind, empathy and insight abilities and clinical correlates in schizoprenia
ALPTEKİN K. (Advisor)
N.ERDİL(Student)
2008
2008Postgraduate
Reliability and validity study of dokuz eylül theory of mind index
ALPTEKİN K. (Advisor)
B.DEĞİRMENCİOĞLU(Student)
2005
2005Expertise In Medicine
Reliability and validity study of Turkish form of thought and language index in schizophrenia patients
ALPTEKİN K. (Advisor)
H.UŞAK(Student)
1999
1999Expertise In Medicine
Cognitive functions and clinical aspects in obsessive compulsive disorder: Relation with event-related auditory potentials (P300) and neuropsychological tests
ALPTEKİN K. (Advisor)
B.BİNNUR(Student)
Articles
All (199)
SCI-E, SSCI, AHCI (166)
SCI-E, SSCI, AHCI, ESCI (172)
ESCI (7)
Scopus (181)
TRDizin (50)
Other Publications (10)
2025
20251. "It's Like I'm Living with a Pharmacy": Experiences of Individuals with Severe Mental Disorders Regarding Psychotropic Medication Polypharmacy
TUNCER G. Z., ÇETİNKAYA DUMAN Z., ALPTEKİN K.
ISSUES IN MENTAL HEALTH NURSING
, 2025 (SCI-Expanded)
2025
20252. The impact of affective and negative symptoms on the development of psychosis in a six-year follow-up of a community-based population
Ergül C., Binbay T., Kırlı U., Elbi H., ALPTEKİN K., van Os J., et al.
Social Psychiatry and Psychiatric Epidemiology
, vol.60, no.6, pp.1357-1366, 2025 (SCI-Expanded)
2025
20253. Relationship between the Use of Mobile Applications and Social Functioning in Patients with Schizophrenia.
Hoşgelen E. I., Akdede B. B., Alptekin K.
Turk psikiyatri dergisi = Turkish journal of psychiatry
, vol.36, pp.138-149, 2025 (SSCI)
2025
20254. Linking prolonged childhood and adolescent loneliness to schizophrenia spectrum disorders: Results from EU-GEI study
Andreu-Bernabeu Á., González-Peñas J., Mora A., Bernardo M., Mezquida G., Amoretti S., et al.
British Journal of Psychiatry
, 2025 (SCI-Expanded)
2024
20245. Reliability and validity study of the Turkish version of the Schizophrenia Cognition Rating Scale (SCoRS-TR)
Özak N., Hoşgelen E. I., AKDEDE B. B., ALPTEKİN K.
Asian Journal of Psychiatry
, vol.102, 2024 (SCI-Expanded)
2024
20246. Virtual Reality Interventions and Psychosocial Functioning in Schizophrenia Spectrum Disorders: A Systematic Review
Hoşgelen E. I., Güneri S., Erdeniz B., ALPTEKİN K.
Clinical Psychology and Psychotherapy
, vol.31, no.6, 2024 (SSCI)
2024
20247. The relationship between childhood trauma, psychotic symptoms, and cognitive schemas in patients with schizophrenia, their siblings, and healthy controls: results from the EU-GEI study.
Üçok A., Noyan H., Gülöksüz S., SAKA M. C., ALPTEKİN K., Atbaşoǧlu C., et al.
Psychological medicine
, vol.54, no.10, pp.2414-2425, 2024 (SCI-Expanded)
2024
20248. Early and late contingent negative variation (CNV) reflect different aspects of deficits in schizophrenia
Akgül Ö., Fide E., ÖZEL F., ALPTEKİN K., BORA İ. E., AKDEDE B. B., et al.
European Journal of Neuroscience
, vol.59, no.11, pp.2875-2889, 2024 (SCI-Expanded)
2024
20249. Enhanced Punishment Responses in Patients With Schizophrenia: An Event-Related Potential Study
Akgül Ö., Fide E., Özel F., ALPTEKİN K., BORA İ. E., AKDEDE B. B., et al.
Clinical EEG and Neuroscience
, vol.55, no.2, pp.219-229, 2024 (SCI-Expanded)
2024
202410. Clustering Schizophrenia Genes by Their Temporal Expression Patterns Aids Functional Interpretation
van der Meer D., Cheng W., Rokicki J., Fernandez-Cabello S., Shadrin A., Smeland O. B., et al.
Schizophrenia Bulletin
, vol.50, no.2, pp.327-338, 2024 (SCI-Expanded)
2024
202411. Treated incidence of first episode psychosis in Sinop, Turkey: results of a 4-year admission-based study - SINOPsy.
Binbay T., Mollaahmetoğlu Ö. M., Kırlı U., Arık D., Alptekin K.
Psychological medicine
, vol.54, no.3, pp.558-568, 2024 (SCI-Expanded)
2024
202412. Reduced Reward Processing in Schizophrenia: A Comprehensive EEG Event-Related Oscillation Study
Akgül Ö., Fide E., Özel F., ALPTEKİN K., BORA İ. E., AKDEDE B. B., et al.
Brain Topography
, vol.37, no.1, pp.126-137, 2024 (SCI-Expanded)
2023
202313. Effect of dual tasking on postural control in individuals with schizophrenia
YILDIRIM M., ELVAN A., Ercegil G., Selmani M., Şimşek İ. E., SAVCI S., et al.
Journal of musculoskeletal & neuronal interactions
, vol.23, no.3, pp.308-315, 2023 (SCI-Expanded)
2023
202314. A 6-year follow-up study in a community-based population: Is neighbourhood-level social capital associated with the risk of emergence and persistence of psychotic experiences and transition to psychotic disorder?
Ergül C., Drukker M., Binbay T., Kırlı U., Elbi H., Alptekin K., et al.
PSYCHOLOGICAL MEDICINE
, vol.53, 2023 (SCI-Expanded)
2023
202315. Deficits in Analytic and Common-Sense Reasoning in Schizophrenia
Bora E., Yalincetin B., Akdede B. B., ALPTEKİN K.
The Journal of nervous and mental disease
, vol.211, no.5, pp.376-381, 2023 (SCI-Expanded)
2023
202316. Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
Fusar-Poli L., Prachason T., Erzin G., Pries L., Brondino N., Politi P., et al.
Psychiatry Research
, vol.323, 2023 (SCI-Expanded)
2023
202317. Clinical and developmental characteristics of cognitive subgroups in a transdiagnostic sample of schizophrenia spcectrum disorders and bipolar disorder
Bora E., Verim B., Akgul O., Ildız A., Ceylan D., ALPTEKİN K., et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY
, vol.68, pp.47-56, 2023 (SCI-Expanded)
2023
202318. The association of social inequality with the onset, persistence, and progression of psychotic experiences along the extended psychosis phenotype: a 6-year follow-up study in a community-based sample
Binbay İ. T., Erel B., Set R. T., Kırlı U., Ergül C., Elbi H., et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
, vol.58, pp.1-14, 2023 (SCI-Expanded)
2023
202319. A Real Environment Based Virtual Reality Psychosocial Treatment May Help Patients with Schizophrenia to Increase Social Functioning: A Preliminary Study
Hoşgelen E. I., Kartelli F., Berger M., Erinç S., Yerlikaya D., Özbek Y., et al.
Turk Psikiyatri Dergisi
, vol.34, no.4, pp.244-253, 2023 (SSCI)
2022
202220. Quality of Life of Individuals with Bipolar Disorder and Schizophrenia
Celik H. E. A., Ceylan D., Bagci B., AKDEDE B. B., ALPTEKİN K., Ozerdem A.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.59, no.4, pp.309-314, 2022 (SCI-Expanded)
2022
202221. Relation between processing speed and social media use in schizophrenia patients
Hosgelen E. I., Akgul O., AKDEDE B. B., ALPTEKİN K.
SCHIZOPHRENIA RESEARCH
, vol.248, pp.290-291, 2022 (SCI-Expanded)
2022
202222. The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study
Fusar-Poli L., Pries L., Van Os J., Radhakrishnan R., Pence A. Y., Erzin G., et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY
, vol.63, pp.1-14, 2022 (SCI-Expanded)
2022
202223. Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway
Van Os J., Pries L., Ten Have M., De Graaf R., Van Dorsselaer S., Delespaul P., et al.
PSYCHOLOGICAL MEDICINE
, vol.52, no.10, pp.1910-1922, 2022 (SCI-Expanded)
2022
202224. A replication study of JTC bias, genetic liability for psychosis and delusional ideation
Henquet C., Van Os J., Pries L. K., Rauschenberg C., Delespaul P., Kenis G., et al.
PSYCHOLOGICAL MEDICINE
, vol.52, no.9, pp.1777-1783, 2022 (SCI-Expanded)
2022
202225. Mapping genomic loci implicates genes and synaptic biology in schizophrenia
Trubetskoy V., Pardinas A. F., Qi T., Panagiotaropoulou G., Awasthi S., Bigdeli T. B., et al.
NATURE
, vol.604, no.7906, pp.502-525, 2022 (SCI-Expanded)
2022
202226. Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study.
Fusar-Poli L., Pries L., van Os J., Erzin G., Delespaul P., Kenis G., et al.
Progress in neuro-psychopharmacology & biological psychiatry
, vol.113, pp.110440, 2022 (SCI-Expanded)
2022
202227. Grammatical Processing in Schizoprenia: Analysis on Sentence Structure
Vural A., Kuruoglu G., Alptekin K.
PSYCHOLINGUISTICS
, vol.31, no.2, pp.95-115, 2022 (ESCI)
2022
202228. Thought Disorder as a Neglected Dimension in Schizophrenia
UZMAN ÖZBEK S., ALPTEKİN K.
ALPHA PSYCHIATRY
, vol.23, no.1, pp.5-11, 2022 (SCI-Expanded)
2021
202129. Views of individuals diagnosed with schizophrenia on working life: a qualitative study
Çetinkaya Duman Z., Tuncer G. Z., Sarı A., Alptekin K.
The Journal of Psychiatric Nursing , vol.12, no.4, pp.341-349, 2021 (ESCI)
2021
202130. Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase
KIRLI U., ALPTEKİN K.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.58, 2021 (SCI-Expanded)
2021
202131. SCHIZOPHRENIA OF THE COVID-19 EPIDEMIC EFFECT ON PATIENTS
Hosgelen E. I., ALPTEKİN K.
TURK PSIKIYATRI DERGISI
, vol.32, no.3, pp.219-221, 2021 (SSCI)
2021
202132. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings
Velthorst E., Mollon J., Murray R. M., de Haan L., Germeys I. M., Glahn D. C., et al.
MOLECULAR PSYCHIATRY
, no.8, pp.4529-4543, 2021 (SCI-Expanded)
2021
202133. Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study.
Erzin G., Pries L., van Os J., Fusar-Poli L., Delespaul P., Kenis G., et al.
European psychiatry : the journal of the Association of European Psychiatrists
, vol.64, no.1, 2021 (SCI-Expanded)
2021
202134. Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1 beta levels in patients with schizophrenia spectrum disorder and their siblings
Noyan H., Erdag E., Tuzun E., Yaylim L., Kucukhuseyin O., Hakan M. T., et al.
SCHIZOPHRENIA RESEARCH
, vol.229, pp.27-37, 2021 (SCI-Expanded)
2021
202135. Opinions of individuals diagnosed with schizophrenia on working life: qualitative study
ÇETİNKAYA DUMAN Z., TUNCER G. Z., SARI A., ALPTEKİN K.
JOURNAL OF PSYCHIATRIC NURSING
, vol.12, no.4, pp.341-349, 2021 (ESCI)
2021
202136. The Relationship between Alcohol-Cannabis Use and Stressful Events with the Development of Incident Clinical Psychosis in a Community-Based Prospective Cohort.
Kirli U., Binbay T., Alptekin K., Kayahan B., Elbi H.
Turk psikiyatri dergisi = Turkish journal of psychiatry
, vol.32, no.4, pp.235-245, 2021 (SSCI)
2020
202037. Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum.
Pries L. -., Dal Ferro G. A., van Os J., Delespaul P., Kenis G., Lin B. D., et al.
Epidemiology and psychiatric sciences
, vol.29, 2020 (SCI-Expanded)
2020
202038. Neurocognitive functioning during symptomatic states and remission in bipolar disorder and schizophrenia: A comparative study
Ceylan D., Akdede B. B., BORA İ. E., Aktener A. Y., HIDIROĞLU ONGUN C., Tunca Z., et al.
PSYCHIATRY RESEARCH
, 2020 (SCI-Expanded)
2020
202039. Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study
van Os J., Pries L., Delespaul P., Kenis G., Luykx J. J., Lin B. D., et al.
PSYCHOLOGICAL MEDICINE
, vol.50, no.11, pp.1884-1897, 2020 (SCI-Expanded)
2020
202040. COVID 19 pandemic and psychotic symptoms
Kırlı U., Binbay T., ELBİ H., ALPTEKİN K.
KLINIK PSIKIYATRI DERGISI-TURKISH JOURNAL OF CLINICAL PSYCHIATRY
, vol.23, pp.81-85, 2020 (ESCI)
2020
202041. Genetic Susceptibility to Clozapine-Induced Agranulocytosis/Neutropenia Across Ethnicities: Results From a New Cohort of Turkish and Other Caucasian Participants, and Meta-Analysis
Okhuijsen-Pfeifer C., Ayhan Y., Lin B. D., Van Eijk K. R., Bekema E., Kool L. J. G. B., et al.
Schizophrenia Bulletin Open
, vol.1, no.1, 2020 (Scopus)
2020
202042. The concept of schizotypy and schizotypal personality disorder
Misir E., ALPTEKİN K.
KLINIK PSIKIYATRI DERGISI-TURKISH JOURNAL OF CLINICAL PSYCHIATRY
, vol.23, no.3, pp.364-374, 2020 (ESCI)
2020
202043. COVID 19 pandemic and psychotic symptoms (tur)
KIRLI U., BİNBAY İ. T., ELBİ H., ALPTEKİN K.
Journal of Clinical Psychiatry
, vol.23, no.1, pp.81-85, 2020 (ESCI)
2019
201944. White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder?
Schepers E., Lousberg R., Guloksuz S., Pries L., Delespaul P., Kenis G., et al.
FRONTIERS IN PSYCHIATRY
, vol.10, 2019 (SCI-Expanded)
2019
201945. Association of Wider Social Environment with Relapse in Schizophrenia: Registry Based Six-Year Follow-Up Study.
Unal B., Akgul O., Binbay T., ALPTEKİN K., Kivircik Akdede B. B.
Noro psikiyatri arsivi
, vol.56, no.4, pp.235-242, 2019 (SCI-Expanded)
2019
201946. Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study
Pries L., Lage-Castellanos A., Delespaul P., Kenis G., Luykx J. J., Lin B. D., et al.
SCHIZOPHRENIA BULLETIN
, vol.45, no.5, pp.960-965, 2019 (SCI-Expanded)
2019
201947. Izmir Mental Health Cohort for Gene-Environment Interaction in Psychosis (TürkSch): Assessment of the Extended and Transdiagnostic Psychosis Phenotype and Analysis of Attrition in a 6-Year Follow-Up of a Community-Based Sample.
Kırlı U., Binbay T., ELBİ H., Drukker M., KAYAHAN B., Ozkinay F., et al.
Frontiers in psychiatry
, vol.10, pp.554, 2019 (SCI-Expanded)
2019
201948. Neurocognitive and linguistic correlates of positive and negative formal thought disorder: A meta-analysis
BORA İ. E., Yalincetin B., AKDEDE B. B., ALPTEKİN K.
SCHIZOPHRENIA RESEARCH
, vol.209, pp.2-11, 2019 (SCI-Expanded)
2019
201949. DSM outcomes of psychotic experiences and associated risk factors: 6-year follow-up study in a community-based sample.
Kirli U., Binbay T., Drukker M., ELBİ H., KAYAHAN B., Gokcelli D. K., et al.
Psychological medicine
, vol.49, no.8, pp.1346-1356, 2019 (SCI-Expanded)
2019
201950. Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study.
Guloksuz S., Pries L., Delespaul P., Kenis G., Luykx J. J., Lin B. D., et al.
World psychiatry : official journal of the World Psychiatric Association (WPA)
, vol.18, no.2, pp.173-182, 2019 (SCI-Expanded)
2019
201951. Relation between smoking and formal thought disorder in schizophrenia
ALPTEKİN K.
EUROPEAN PSYCHIATRY
, vol.56, 2019 (SCI-Expanded)
2019
201952. Psychometric liability to psychosis and childhood adversities are associated with shorter telomere length: A study on schizophrenia patients, unaffected siblings, and non-clinical controls
Cevik B., Mance-Calisir O., ATBAŞOĞLU E. C., SAKA M. C., ALPTEKİN K., Ucok A., et al.
JOURNAL OF PSYCHIATRIC RESEARCH
, vol.111, pp.169-185, 2019 (SCI-Expanded)
2019
201953. Schizophrenia in microcephalic osteodysplastic primordial dwarfism type II syndrome: supporting evidence for an association between the PCNT gene and schizophrenia
Ozel F., Direk N., Kulali M. A., GİRAY BOZKAYA Ö., ADA E., ALPTEKİN K.
PSYCHIATRIC GENETICS
, vol.29, no.2, pp.57-60, 2019 (SCI-Expanded)
2019
201954. Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study
Kirli U., BİNBAY İ. T., Drukker M., ELBİ H., KAYAHAN B., Gokcelli D. K., et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
, vol.180, no.2, pp.113-121, 2019 (SCI-Expanded)
2019
201955. Psychotic experiences and mood episodes predict each other bidirectionally: a 6-year follow-up study in a community-based population
Kirli U., BİNBAY İ. T., Drukker M., van Os J., ALPTEKİN K., KAYAHAN B., et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
, vol.54, no.3, pp.331-341, 2019 (SCI-Expanded)
2019
201956. Burnout in Chest Physicians after Health Care Reforms: A Cross-Sectional Study in Turkey.
Atik M., UÇAN E. S., ELLİDOKUZ H., ALPTEKİN K.
Turkish thoracic journal
, vol.20, no.1, pp.18-24, 2019 (Scopus, TRDizin)
2018
201857. The Validity and Reliability Study of The Dokuz Eylul Theory of Mind Index (DEZIKO) in Patients with Schizophrenia
Degirmencioglu B., ALPTEKİN K., AKDEDE B. B., Erdil N., Aktener A., Mantar A., et al.
TURK PSIKIYATRI DERGISI
, vol.29, no.3, 2018 (SSCI)
2018
201858. he Validity and Reliability Study of the Dokuz Eylül Theory of Mind Index (DEZİKÖ) in Patients with Schizophrenia
DEĞİRMENCİOĞLU B., ALPTEKİN K., KIVIRCIK B. B. A., ERDİL N., AKTENER A., MANTAR A., et al.
Türk Psikiyatri Dergisi
, vol.29, no.3, pp.193-201, 2018 (SSCI)
2018
201859. The Association between the Extended Psychosis Phenotype and COMT val158met and BDNF val66met polymorphisms
BİNBAY İ. T., KIRLI U., MISIR E., ELBİ H., KAYAHAN B., ONAY H., et al.
Türk Psikiyatri Dergisi
, vol.29, no.4, pp.221-228, 2018 (SSCI)
2018
201860. Is There Any Relation Between Impaired Emotion Perception and Thought Disorder in Schizophrenia?
Yildirim E., Yalincetin B., Sevilmis S., Kutay O., ALPTEKİN K.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.55, no.2, pp.118-122, 2018 (SCI-Expanded)
2018
201861. The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis - CORRIGENDUM.
Bora E., Akdede B. B., Alptekin K.
Psychological medicine
, vol.48, no.7, pp.1224, 2018 (SCI-Expanded)
2018
201862. Higher schizotypy predicts better metabolic profile in unaffected siblings of patients with schizophrenia
ATBAŞOĞLU E. C., GÜMÜŞ-AKAY G., Guloksuz S., SAKA M. C., Ucok A., ALPTEKİN K., et al.
PSYCHOPHARMACOLOGY
, vol.235, no.4, pp.1029-1039, 2018 (SCI-Expanded)
2018
201863. Duration of untreated psychosis and neurocognition in first-episode psychosis: A meta-analysis
BORA İ. E., Yalincetin B., AKDEDE B. B., ALPTEKİN K.
SCHIZOPHRENIA RESEARCH
, vol.193, pp.3-10, 2018 (SCI-Expanded)
2018
201864. İzmir Kent Merkezinde Şizofreni ve Psikotik Belirtili Bozuklukların Yaşamboyu Yaygınlığı ve İlişkili Oldukları Sosyodemografik Özellikler
BİNBAY İ. T., ALPTEKİN K., ELBİ H., ZAĞLI N., DRUKKER M., AKSU TANIK F. B., et al.
Türk Psikiyatri Dergisi , vol.23, no.3, pp.149-160, 2018 (SSCI)
2018
201865. [The Association between the Extended Psychosis Phenotype and COMT val158met and BDNF val66met polymorphisms].
Binbay T., Kirli U., Misir E., ELBİ H., KAYAHAN B., Onay H., et al.
Turk psikiyatri dergisi = Turkish journal of psychiatry
, vol.29, no.4, pp.221-228, 2018 (SCI-Expanded)
2017
201766. Psychotic Experiences in the Adaptation Process to a New Social Environment
BİNBAY İ. T., MISIR E., ÖZSOYDAN E. O., ARTUK M., FİDAN S., KARAKİRAZ A., et al.
Türk Psikiyatri Dergisi
, vol.28, no.1, pp.1-10, 2017 (SSCI)
2017
201767. Cavum Vergae, Liability, and Steroid Treatment: Manic Episode, Brain Imaging Findings, and Clinical Follow-up of a Systemic Lupus Erythematosus Case
Misir E., BİNBAY İ. T., Targitay B., Arat H. E., CAN G., ALPTEKİN K.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.54, no.4, pp.372-375, 2017 (SCI-Expanded)
2017
201768. Neurocognitive impairment in deficit and non-deficit schizophrenia: a meta-analysis
BORA İ. E., Akdede B. B., ALPTEKİN K.
PSYCHOLOGICAL MEDICINE
, vol.47, no.14, pp.2401-2413, 2017 (SCI-Expanded)
2017
201769. Impact of parental consanguinity on clinical features in schizophrenia
BİNBAY İ. T., BİNBAY D. A., ULAŞ H., AKDEDE B. B., ALPTEKİN K.
Anadolu Psikiyatri Dergisi
, vol.18, no.1, pp.22-28, 2017 (SCI-Expanded)
2017
201770. The epidemiology of alcohol use in Izmir, Turkey: drinking pattern, impairment and help-seeking
Ulas H., BİNBAY İ. T., Kirli U., ELBİ H., ALPTEKİN K.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
, vol.52, no.7, pp.887-899, 2017 (SCI-Expanded)
2017
201771. Formal thought disorder in schizophrenia and bipolar disorder: A systematic review and meta-analysis
Yalincetin B., BORA İ. E., BİNBAY İ. T., Ulas H., AKDEDE B. B., ALPTEKİN K.
SCHIZOPHRENIA RESEARCH
, vol.185, pp.2-8, 2017 (SCI-Expanded)
2017
201772. The Production of Simple Sentence Structures in Schizophrenia
ÖZCAN A., KURUOĞLU G., ALPTEKİN K., AKDEDE B. B., ÖZSOY S., SEVİLMİŞ Ş., et al.
INTERNATIONAL JOURNAL OF ARTS AND SCIENCES , vol.9, no.4, pp.159-164, 2017 (Peer-Reviewed Journal)
2017
201773. An Analysis of Complex Sentence Structures of TurkishSchizophrenia Patients
ÖZCAN A., KURUOĞLU G., ALPTEKİN K., ÖZSOY S.
Global Journal of ForeignLanguage Teaching , vol.6, no.4, pp.228-235, 2017 (Peer-Reviewed Journal)
2017
201774. Postural control and executive functioning in patients with schizophrenia
Yildirim M., Elvan A., Ercegil G., Simsek I. E., Savci S., ALPTEKİN K.
EUROPEAN PSYCHIATRY
, vol.41, 2017 (SCI-Expanded)
2017
201775. The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis
BORA İ. E., Akdede B. B., ALPTEKİN K.
PSYCHOLOGICAL MEDICINE
, vol.47, no.6, pp.1030-1040, 2017 (SCI-Expanded)
2017
201776. Psychotic Experiences in the Adaptation Process to a New Social Environment
BİNBAY İ. T., Misir E., Onrat Ozsoydan E., Artuk M., Fidan S., Karakiraz A., et al.
TURK PSIKIYATRI DERGISI
, vol.28, no.1, 2017 (SSCI)
2017
201777. Impact of parental consanguinity on clinical features in schizophrenia
BİNBAY İ. T., Arik Binbay D., Ulas H., AKDEDE B. B., ALPTEKİN K.
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY
, vol.18, no.1, pp.22-28, 2017 (SCI-Expanded)
2017
201778. Do clinical features relate to theory of mind, empathy and 2D:4D in schizophrenia?
Akgul O., Kucukcoban O., BİNBAY İ. T., BORA İ. E., ALPTEKİN K., AKDEDE B. B.
PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY
, vol.27, no.4, pp.380-385, 2017 (SCI-Expanded)
2016
201679. Assessing thought disorder in patients with schizophrenia
Yalnçetin B., Akgül Ö., ALPTEKİN K.
Psychiatria
, vol.13, no.4, pp.194-197, 2016 (Scopus)
2016
201680. The associatons of the antipsychotic polypharmacy in schizophrenia treatment with the symptoms, side effects and the quality of life
Ceylan D., Yesilyurt S., AKDEDE B. B., Sayin Z., ALPTEKİN K.
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY
, vol.17, no.6, pp.433-441, 2016 (SCI-Expanded)
2016
201681. Relation of formal thought disorder to symptomatic remission and social functioning in schizophrenia
Yalincetin B., Ulas H., Var L., BİNBAY İ. T., AKDEDE B. B., ALPTEKİN K.
COMPREHENSIVE PSYCHIATRY
, vol.70, pp.98-104, 2016 (SCI-Expanded)
2016
201682. Formal thought disorder in first-episode psychosis
Ayer A., Yalincetin B., Aydinli E., Sevilmis S., Ulas H., BİNBAY İ. T., et al.
COMPREHENSIVE PSYCHIATRY
, vol.70, pp.209-215, 2016 (SCI-Expanded)
2016
201683. Admission-Based Prevalence of Schizophrenia, Schizoaffective Disorder and Bipolar I Disorder in a Catchment Area in Sinop, Turkey
BİNBAY İ. T., Arik Binbay D., Ulas H., ALPTEKİN K.
TURK PSIKIYATRI DERGISI
, vol.27, no.3, pp.151-160, 2016 (SSCI)
2015
201584. Cavum Vergae and Schizophrenia: Brain Imaging Findings and Treatment Outcome of a Case with 25 Years of Untreated Psychosis
Sagir B., BİNBAY İ. T., Ceylan D., Yalin N., Ozerdem A., ALPTEKİN K.
TURK PSIKIYATRI DERGISI
, vol.26, no.4, pp.295-298, 2015 (SSCI)
2015
201585. Nurses' perceptions of medication adherence in schizophrenia: results of the ADHES cross-sectional questionnaire survey
Emsley R., ALPTEKİN K., Azorin J., Canas F., Dubois V., Gorwood P., et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY
, vol.5, no.6, pp.339-350, 2015 (SCI-Expanded)
2015
201586. Relationship between thought and language disorder with Positive and Negative Syndrome Scale and sociodemographic characteristics in patients with schizophrenia
Ulas H., Yalincetin B., BİNBAY İ. T., Kivircik B. B., Polat S., Ozbay D., et al.
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY
, vol.16, no.5, pp.307-313, 2015 (SCI-Expanded)
2015
201587. The epidemiology of major depressive disorder and subthreshold depression in Izmir, Turkey: Prevalence, socioeconomic differences, impairment and help-seeking
Topuzoglu A., BİNBAY İ. T., Ulas H., ELBİ H., Tanik F. A., Zagli N., et al.
JOURNAL OF AFFECTIVE DISORDERS
, vol.181, pp.78-86, 2015 (SCI-Expanded)
2015
201588. Brain morphometry and electrophysiological recordings in relation to illness duration in schizophrenia
KARABAY N., Öniz A., Taşlica S., ALPTEKİN K., Hugdahl K., Özgören M.
Neuroscience Letters
, vol.593, pp.118-123, 2015 (SCI-Expanded)
2015
201589. The Relation of Thought-language Disorders in Schizophrenia with Remission of Symptoms and Psychosocial Improvement
Yalincetin B., ALPTEKİN K., Var L., BİNBAY İ. T., Akdede B.
EUROPEAN PSYCHIATRY
, vol.30, 2015 (SCI-Expanded)
2014
201490. Psychiatric Epidemiology in Turkey: Main Advances in Recent Studies and Future Directions
BİNBAY İ. T., Direk N., Aker T., AKVARDAR Y., ALPTEKİN K., CİMİLLİ H. C., et al.
TURK PSIKIYATRI DERGISI
, vol.25, no.4, pp.264-281, 2014 (SSCI)
2014
201491. Koruyucu Psikiyatri Açısından Şizofreni: Şizofreniden Temel Korunma Schizophrenia from the Perspective of Preventive Psychiatry: The Primary Prevention of Schizophrenia
SOYGÜR A. H., ALPTEKİN K.
Turkiye Klinikleri Psychiatry - Special Topics Journal Identity , vol.4, no.4, pp.49-56, 2014 (Peer-Reviewed Journal)
2014
201492. Increase in antipsychotic polypharmacy treatment in patients with schizophrenia between 1994-2000 and 2010
CEYLAN TUFAN ÖZALP D., AKTENER A., AKDEDE B. B., ALPTEKİN K.
CURRENT PSYCHOPHARMACOLOGY , vol.3, no.2, pp.108-112, 2014 (Peer-Reviewed Journal)
2014
201493. Treatment Guidelines for Patients with Schizophrenia or Psychotic Disorder who are Hospitalized in a Psychiatry Clinic
ALPTEKİN K., Ucok A., Ayer A., Unal A., Erol A., Ensari H., et al.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
, vol.24, no.3, pp.276-288, 2014 (SCI-Expanded)
2014
201494. The role of dopamine2 receptor gene and personality characteristics in alcohol dependence in Turkish population
Dalmis A., AKVARDAR Y., ERESEN YAZICIOĞLU Ç., KIZILDAĞ S., Akpulat U., Yildirimcan S., et al.
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY
, vol.15, no.3, pp.192-199, 2014 (SCI-Expanded)
2014
201495. Identifying Gene-Environment Interactions in Schizophrenia: Contemporary Challenges for Integrated, Large-scale Investigations
van Os J., Rutten B. P., Myin-Germeys I., Delespaul P., Viechtbauer W., van Zelst C., et al.
SCHIZOPHRENIA BULLETIN
, vol.40, no.4, pp.729-736, 2014 (SCI-Expanded)
2014
201496. RELATION OF RGS4 GENE WITH SCHIZOPHRENIA
Gulsu E., ERESEN YAZICIOĞLU Ç., KIZILDAĞ S., Degirmencioglu B., Taslica S., ALPTEKİN K.
SCHIZOPHRENIA RESEARCH
, vol.153, 2014 (SCI-Expanded)
2014
201497. RELATION BETWEEN PSYCHOTIC-LIKE EXPERIENCES AND MAJOR DEPRESSION IN THE COMMUNITY BASED SAMPLE
Topuzoglu A., Binbay T., ELBİ H., Zagli N., Onay H., ÖZKINAY F. F., et al.
SCHIZOPHRENIA RESEARCH
, vol.153, 2014 (SCI-Expanded)
2014
201498. THE ASSOCIATION BETWEEN THOUGHT DISORDER AND MEMORY IMPAIRMENTS IN FIRST-EPISODE PSYCHOSIS
Demir S. S., Aydinli E., Ayer A., Yalincetin B., AKDEDE B. B., ALPTEKİN K.
SCHIZOPHRENIA RESEARCH
, vol.153, 2014 (SCI-Expanded)
2014
201499. FAMILIAL LIABILITY, THE BDNF-VAL66MET POLYMORPHISM AND PSYCHOTIC-LIKE EXPERIENCES
ALPTEKİN K., Binbay T., ELBİ H., Zagli N., Onay H., Ozkinay F., et al.
SCHIZOPHRENIA RESEARCH
, vol.153, 2014 (SCI-Expanded)
2014
2014100. AN ASSOCIATION STUDY OF RGS4 POLYMORPHISMS WITH CLINICAL AND NEUROCOGNITIVE PROFILES OF SCHIZOPHRENIA PATIENTS
Can G., Gulsu E., Degirmencioglu B., Topuzoglu A., ERESEN YAZICIOĞLU Ç., AKDEDE B. B., et al.
SCHIZOPHRENIA RESEARCH
, vol.153, 2014 (SCI-Expanded)
2014
2014101. THOUGHT DISORDERS AND FAMILY LIABILITY IN FIRST EPISODE PSYCHOSIS
Aydinli E., Sevilmis S., Ayer A., Yalincetin B., AKDEDE B. B., ALPTEKİN K.
SCHIZOPHRENIA RESEARCH
, vol.153, 2014 (SCI-Expanded)
2014
2014102. THE IMPACT OF CONSANGUINITY ON RISK OF EXTENDED PSYCHOSIS PHENOTYPE
Binbay T., ALPTEKİN K., ELBİ H., Ulas H., Drukker M., van Os J.
SCHIZOPHRENIA RESEARCH
, vol.153, 2014 (SCI-Expanded)
2014
2014103. RELATIONSHIP OF KREMEN1 GENE VARIATION WITH SYMPTOMATOLOGY AND COGNITIVE FUNCTIONING IN SCHIZOPHRENIA
Degirmencioglu B., Ozsoylu D., Can G., ERESEN YAZICIOĞLU Ç., AKDEDE B. B., ALPTEKİN K.
SCHIZOPHRENIA RESEARCH
, vol.153, 2014 (SCI-Expanded)
2014
2014104. INVESTIGATION OF THE RELATIONSHIP BETWEEN SCHIZOPHRENIA AND KREMEN1 GENE
Ozsoylu D., Degirmencioglu B., ERESEN YAZICIOĞLU Ç., ALPTEKİN K.
SCHIZOPHRENIA RESEARCH
, vol.153, 2014 (SCI-Expanded)
2014
2014105. THOUGHT DISORDER IN FIRST-EPISODE PSYCHOSIS
Ayer A., Aydinli E., Sevilmis S., Yalincetin B., AKDEDE B. B., ALPTEKİN K.
SCHIZOPHRENIA RESEARCH
, vol.153, 2014 (SCI-Expanded)
2014
2014106. ONE-YEAR PREVALENCE OF MAJOR DEPRESSIVE DISORDER AND RELATED SOCIOECONOMIC FACTORS IN IZMIR CITY CENTER
Binbay T., Topuzoglu A., ELBİ H., ALPTEKİN K., Zagli N., Misir E., et al.
EUROPEAN PSYCHIATRY
, vol.29, 2014 (SCI-Expanded)
2014
2014107. FAMILIAL LIABILITY, THE BDNF-VAL66MET POLYMORPHISM AND PSYCHOTIC-LIKE EXPERIENCES
ALPTEKİN K., Binbay T., ELBİ H., Zagli N., Onay H., Ozkinay F., et al.
EUROPEAN PSYCHIATRY
, vol.29, 2014 (SCI-Expanded)
2013
2013108. Relation between antipsychotic polypharmacy, symptom domains and the quality of life in schizophrenia and schizoaffective disorder
Ceylan D., Yesilyurt S., Akdede B., Topuzoglu A., Sayin Z., Dirioz M., et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY
, vol.23, 2013 (SCI-Expanded)
2013
2013109. Change in the pharmacotherapy of schizophrenia patients over a period of 10 years
Ceylan D., Aktener A., Akdede B., ALPTEKİN K.
EUROPEAN NEUROPSYCHOPHARMACOLOGY
, vol.23, 2013 (SCI-Expanded)
2013
2013110. Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa
Manuel Olivares J., ALPTEKİN K., Azorin J., Canas F., Dubois V., Emsley R., et al.
PATIENT PREFERENCE AND ADHERENCE
, vol.7, pp.121-132, 2013 (SCI-Expanded)
2013
2013111. Improving Treatment Adherence in Your Patients with Schizophrenia
Canas F., ALPTEKİN K., Azorin J. M., Dubois V., Emsley R., Garcia A. G., et al.
CLINICAL DRUG INVESTIGATION
, vol.33, no.2, pp.97-107, 2013 (SCI-Expanded)
2013
2013112. The Relationship Between Illness Duration And Brain Morphometry in Schizophrenia: Heschl’xxs Gyrus and Prefrontal Cortex Volumetry
KARABAY N., ÖNİZ A., GÖKÇAY D., ALPTEKİN K., hugdahl k., ÖZGÖREN M.
Journal of Neurological Sciences , vol.30, no.1, pp.153-167, 2013 (Peer-Reviewed Journal)
2013
2013113. The Relationship Between Illness Duration And Brain Morphometry in Schizophrenia: Heschl's Gyrus and Prefrontal Cortex Volumetry
KARABAY N., Oniz A., GÖKÇAY D., ALPTEKİN K., Hugdahl K., Ozgoren M.
JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH
, vol.30, no.1, pp.153-167, 2013 (SCI-Expanded)
2012
2012114. Evidence that the wider social environment moderates the association between familial liability and psychosis spectrum outcome
BİNBAY İ. T., Drukker M., ALPTEKİN K., ELBİ H., Tanik F. A., Ozkinay F., et al.
PSYCHOLOGICAL MEDICINE
, vol.42, no.12, pp.2499-2510, 2012 (SCI-Expanded)
2012
2012115. Testing the Psychosis Continuum: Differential Impact of Genetic and Nongenetic Risk Factors and Comorbid Psychopathology Across the Entire Spectrum of Psychosis
BİNBAY İ. T., Drukker M., ELBİ H., Tanik F. A., Ozkinay F., Onay H., et al.
SCHIZOPHRENIA BULLETIN
, vol.38, no.5, pp.992-1002, 2012 (SCI-Expanded)
2012
2012116. Lifetime Prevalence and Correlates of Schizophrenia and Disorders with Psychotic Symptoms in the General Population of Izmir, Turkey
BİNBAY İ. T., ALPTEKİN K., ELBİ H., Zagli N., Drukker M., Tanik F. A., et al.
TURK PSIKIYATRI DERGISI
, vol.23, no.3, pp.149-160, 2012 (SSCI)
2012
2012117. Auditory verbal hallucinations in schizophrenia as aberrant lateralized speech perception: Evidence from dichotic listening
Hugdahl K., Loberg E., Falkenberg L. E., Johnsen E., Kompus K., Kroken R. A., et al.
SCHIZOPHRENIA RESEARCH
, vol.140, pp.59-64, 2012 (SCI-Expanded)
2012
2012118. SYMPTOMATIC REMISSION IN SCHIZOPHRENIA: RELATION OF COGNITIVE FUNCTIONS AND CLINICAL FEATURES
Aktener A. Y., AKDEDE B. B., Degirmecioglu B., ALPTEKİN K.
SCHIZOPHRENIA RESEARCH
, vol.136, 2012 (SCI-Expanded)
2012
2012119. THE EMEA ADHES SURVEY IN SCHIZOPHRENIA: NURSES' PERCEPTIONS OF THE EXTENT AND BURDEN OF PARTIAL AND NON-ADHERENCE TO MEDICATION IN PATIENTS WITH SCHIZOPHRENIA
Emsley R., ALPTEKİN K., Azorin J. -., Canas F., Dubois V., Gorwood P., et al.
SCHIZOPHRENIA RESEARCH
, vol.136, 2012 (SCI-Expanded)
2012
2012120. THE EMEA ADHES SURVEY IN SCHIZOPHRENIA: NURSES' VIEWS ON THE TREATMENT OPTIONS FOR IMPROVING PARTIAL OR NON-ADHERENCE IN PATIENTS WITH SCHIZOPHRENIA
Emsley R., ALPTEKİN K., Azorin J. -., Canas F., Dubois V., Gorwood P., et al.
SCHIZOPHRENIA RESEARCH
, vol.136, 2012 (SCI-Expanded)
2012
2012121. TRIES: AN OPEN, RANDOMIZED, PROSPECTIVE, MULTICENTER STUDY, SEARCHING THE BEST SWITCH POLICY OF SERTINDOLE IN PATIENTS WITH SCHIZOPHRENIA
ALPTEKİN K., Akdede B., Soygur H.
SCHIZOPHRENIA RESEARCH
, vol.136, 2012 (SCI-Expanded)
2012
2012122. CHANGE IN PSYCHOPHARMACOTHERAPY OF SCHIZOPHRENIA PATIENTS WITHIN A PERIOD OF 10 YEARS
Ceylan D., Aktene A. Y., Kivircik B. B. A., ALPTEKİN K.
SCHIZOPHRENIA RESEARCH
, vol.136, 2012 (SCI-Expanded)
2012
2012123. THE ASSOCIATION BETWEEN THOUGHT-LANGUAGE DISORDER AND REMISSION IN SCHIZOPHRENIA
Var L., Yalincetin B., Ulas H., Polat S., Sevilmis S., AKDEDE B. B., et al.
SCHIZOPHRENIA RESEARCH
, vol.136, 2012 (SCI-Expanded)
2012
2012124. THE ASSOCIATION BETWEEN THOUGHT-LANGUAGE DISORDER AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
Yalincetin B., Var L., Degirmencioglu B., Sevilmis S., Yavas E., Ulas H., et al.
SCHIZOPHRENIA RESEARCH
, vol.136, 2012 (SCI-Expanded)
2012
2012125. Psychotic disorders among immigrants from Turkey in Western Europe: An overview of incidences, prevalence estimates, and admission rates
BİNBAY İ. T., Ulas H., ALPTEKİN K., ELBİ H.
TURK PSIKIYATRI DERGISI
, vol.23, no.1, pp.53-62, 2012 (SSCI)
2012
2012126. Şizofrenide Öne Çıkan Yeni Bir Boyut: Sosyal Biliş / A New Featured Dimension in Schizophrenia : Social Cognition
YILDIRIM E., ALPTEKİN K.
Dusunen Adam: The Journal of Psychiatry and Neurological Sciences
, vol.25, pp.368-375, 2012 (Scopus)
2012
2012127. NURSES' PERCEPTIONS OF ASSESSMENT, CAUSES AND MANAGEMENT OF PARTIAL/NON-ADHERENCE TO MEDICATION: RESULTS OF THE EMEA ADHES SURVEY IN SCHIZOPHRENIA
Emsley R., ALPTEKİN K., Azorin J. -., Canas F., Dubois V., Gorwood P., et al.
EUROPEAN PSYCHIATRY
, vol.27, 2012 (SCI-Expanded)
2011
2011128. A Study of Young Adults who Attempted Suicide in Turkey
ALPTEKİN K., Duyen V.
INDIAN JOURNAL OF SOCIAL WORK
, vol.72, no.3, pp.419-440, 2011 (SSCI)
2011
2011129. Izmir Mental Health Survey for Gene-Environment Interaction in Psychoses (TurkSch): Objectives and Methodology
BİNBAY İ. T., ELBİ H., ALPTEKİN K., Tanik F. A., Drukker M., Onay H., et al.
TURK PSIKIYATRI DERGISI
, vol.22, no.2, pp.65-76, 2011 (SSCI)
2011
2011130. The psychosis epidemiology in Turkey: A systematic review on prevalence estimates and admission rates
BİNBAY İ. T., Ulas H., ELBİ H., ALPTEKİN K.
TURK PSIKIYATRI DERGISI
, vol.22, no.1, pp.40-52, 2011 (SSCI)
2011
2011131. THE EMEA ADHES SURVEY IN SCHIZOPHRENIA: PSYCHIATRISTS' PERCEPTIONS OF THE EXTENT OF ASSESSMENT AND MANAGEMENT OF PARTIAL AND NON-ADHERENCE TO MEDICATION
Naber D., ALPTEKİN K., Azorin J. M., Canas F., Dubois V., Emsley R., et al.
EUROPEAN PSYCHIATRY
, vol.26, 2011 (SCI-Expanded)
2011
2011132. THE EMEA ADHES SURVEY IN SCHIZOPHRENIA: PSYCHIATRISTS' PERCEPTIONS OF REASONS FOR PARTIAL OR NON-ADHERENCE
Gorwood P., ALPTEKİN K., Azorin J. M., Canas F., Dubois V., Emsley R., et al.
EUROPEAN PSYCHIATRY
, vol.26, 2011 (SCI-Expanded)
2011
2011133. THE EMEA ADHES SURVEY IN SCHIZOPHRENIA, AN INITIATIVE TO RAISE AWARENESS OF NON-ADHERENCE TO MEDICATION. DEMOGRAPHICS AND METHODOLOGY
Olivares J. M., ALPTEKİN K., Azorin J. M., Canas F., Dubois V., Emsley R., et al.
EUROPEAN PSYCHIATRY
, vol.26, 2011 (SCI-Expanded)
2010
2010134. Patient adherence and efficacy of quetiapine treatment in schizophrenia: results of a multicentre, naturalistic 6-month follow-up study
ALPTEKİN K., Aydin H., Gucer K. M., Dilbaz N., Goka E., Esendemir C., et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
, vol.25, no.6, pp.342-348, 2010 (SCI-Expanded)
2010
2010135. Impact of panic attacks on quality of life among patients with schizophrenia
Ulas H., Polat S., AKDEDE B. B., ALPTEKİN K.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
, vol.34, no.7, pp.1300-1305, 2010 (SCI-Expanded)
2010
2010136. [Do general practitioners diagnose and treat patients with alcohol use problems?].
Akvardar Y., Ucku R., ÜNAL B., GÜNAY T., AKDEDE B. B., ERGÖR G., et al.
Turk psikiyatri dergisi = Turkish journal of psychiatry
, vol.21, no.1, pp.5-13, 2010 (SSCI)
2010
2010137. Do general practitioners diagnose and treat patients with alcohol use problems?
AKVARDAR Y., Uçku R., ÜNAL B., GÜNAY T., AKDEDE B. B., ERGÖR G., et al.
Türk Psikiyatri Dergisi
, vol.21, no.1, pp.5-13, 2010 (SSCI)
2010
2010138. Şizofreni Epidemiyolojisine Türkiye den Katkı Yapmak Nasıl ve Neden
BİNBAY İ. T., ULAŞ H., ALPTEKİN K.
Klinik Psikiyatri Dergisi , vol.13, no.Ek 1, pp.9-15, 2010 (Peer-Reviewed Journal)
2009
2009139. Prevalence and risk factors of psychotic symptoms: in the city of Izmir, Turkey
ALPTEKİN K., Ulas H., AKDEDE B. B., Tuemueklue M., Akvardar Y.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
, vol.44, no.11, pp.905-910, 2009 (SCI-Expanded)
2009
2009140. Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study
ALPTEKİN K., Hafez J., Brook S., AKKAYA C., Tzebelikos E., Ucok A., et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
, vol.24, no.5, pp.229-238, 2009 (SCI-Expanded)
2009
2009141. European network for promoting the physical health of residents in psychiatric and social care facilities (HELPS): background, aims and methods
Weiser P., Becker T., Losert C., ALPTEKİN K., Berti L., Burti L., et al.
BMC PUBLIC HEALTH
, vol.9, 2009 (SCI-Expanded)
2009
2009142. Sexual dysfunctions induced by antipsychotic medications in patients with schizophrenia Antipsikotik tedavi almakta olan şizofreni hastalarinda görülen cinsel i̇şlev bozukluklari
Tümüklü M. N., ULAŞ H., Akdede B. B. K., ALPTEKİN K.
Klinik Psikofarmakoloji Bulteni
, vol.19, no.SUPPL. 1, 2009 (SCI-Expanded)
2009
2009143. Sexual dysfunctions induced by antipsychotic medications in patients with schizophrenia
Tumuklu M. N., Ulas H., AKDEDE B. B., ALPTEKİN K.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
, vol.19, 2009 (SCI-Expanded)
2009
2009144. RECOVERY ISSUES IN THE TREATMENT OF SCHIZOPHRENIA: ARE WE AT THE END, OR STILL AT THE BEGINNING?
ALPTEKİN K.
EUROPEAN PSYCHIATRY
, vol.24, 2009 (SCI-Expanded)
2009
2009145. Management of Patients Presenting with Acute Psychotic Episodes of Schizophrenia
Thomas P., ALPTEKİN K., Gheorghe M., Mauri M., Manuel Olivares J., Riedel M.
CNS DRUGS
, vol.23, no.3, pp.193-212, 2009 (SCI-Expanded)
2009
2009146. THE REALITY OF TAKING ANTIPSYCHOTIC MEDICATION
ALPTEKİN K.
EUROPEAN PSYCHIATRY
, vol.24, 2009 (SCI-Expanded)
2008
2008147. Financial Conflict of Interest in Clinical Psychiatry Studies: A Review
Ulas H., Binbay I. T., ALPTEKİN K.
TURK PSIKIYATRI DERGISI
, vol.19, no.4, pp.418-426, 2008 (SSCI)
2008
2008148. Şizofrenide nörofizyolojik ve nörokognitif genetik belirleyicilerin endofenotip yeri
ULAŞ H., ALPTEKİN K., TAŞLICA S.
Klinik Psikiyatri Dergisi , vol.11, no.Ek 4, pp.12-19, 2008 (Peer-Reviewed Journal)
2008
2008149. Arrhythmic Markers and Clozapine in Patients with Schizophrenia: Effect of 10 weeks Clozapine Treatment on Heart Rate Variability, Late Potentials and QT Dispersion
Tuemueklue M. N., ALPTEKİN K., Kirimli O., Aslan O., AKDEDE B. B., Badak Ö., et al.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
, vol.18, no.3, pp.167-173, 2008 (SCI-Expanded)
2008
2008150. New generation antipsychotics in the treatment of schizophrenia: dopamine stabilizing agents and aripiprazole
ALPTEKİN K.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
, vol.18, 2008 (SCI-Expanded)
2008
2008151. Role of the social work profession in works for suicide prevention
ALPTEKİN K., Duyan V., Ucan O.
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY
, vol.9, no.3, pp.179-187, 2008 (SCI-Expanded)
2008
2008152. Increased hexosaminidase activity in antipsychotic-induced extrapyramidal side effects: Possible association with higher occurrence in bipolar disorder patients
Tunca Z., Resmi H., ÖZKARA H. A., Ciliv G., ÇELTİKÇİ B., ALPTEKİN K., et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
, vol.32, no.5, pp.1214-1220, 2008 (SCI-Expanded)
2008
2008153. Efficacy and tolerability of switching from olanzapine, risperidone and haloperidol to ziprasidone in patients with schizophrenia: An international multi-center study
ALPTEKİN K., Karayal O. N., Brook S., Akkaya C., Tzebelikos E.
EUROPEAN PSYCHIATRY
, vol.23, 2008 (SCI-Expanded)
2008
2008154. Effect of thought disorders on quality of life in patients with schizophrenia
Ulas H., Akdede B. B., Ozbay D., ALPTEKİN K.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
, vol.32, no.2, pp.332-335, 2008 (SCI-Expanded)
2008
2008155. Practical issues with amisulpride in the management of patients with schizophrenia
Pani L., Villagran J. M., Kontaxakis V. P., ALPTEKİN K.
CLINICAL DRUG INVESTIGATION
, vol.28, no.8, pp.465-477, 2008 (SCI-Expanded)
2007
2007156. Factors associated with dropout and noncompliance in patients with schizophrenia: Results of a one-year follow-up
Üçok A., YAZICI M. K., Mete L., Kültür S., Göǧüs A., Erkoç K., et al.
Clinical Schizophrenia and Related Psychoses
, vol.1, no.2, pp.161-167, 2007 (Scopus)
2007
2007157. Panic symptoms in schizophrenia: Comorbidity and clinical correlates
Ulas H., ALPTEKİN K., AKDEDE B. B., Tumuklu M., Akvardar Y., Kitis A., et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES
, vol.61, no.6, pp.678-680, 2007 (SCI-Expanded)
2007
2007158. Şizofreni Alanında Türkiye deki Epidemiyolojik Veriler ve Gereklilikler
ULAŞ H., BİNBAY İ. T., ALPTEKİN K.
Klinik Aktüel Tıp NöroPsikiyatri Forumu , vol.1, no.1, pp.44-47, 2007 (Peer-Reviewed Journal)
2007
2007159. Şizofrenide Psikososyal Etkenlerin Yeniden Önem Kazanması
BİNBAY İ. T., ULAŞ H., ALPTEKİN K.
Psikiyatride Derlemeler, Olgular ve Varsayımlar (RCHP) , vol.1, no.3, pp.39-48, 2007 (Peer-Reviewed Journal)
2007
2007160. Cognitive dysfunctions in patients with obsessive-compulsive disorder compared to the patients with schizophrenia patients: Relation to overvalued ideas
Kitis A., Akdede B. B., ALPTEKİN K., Akvardar Y., Arkar H., Erol A., et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
, vol.31, no.1, pp.254-261, 2007 (SCI-Expanded)
2007
2007161. Dil ve Düşünce Ölçeğinin Geçerlilik ve Güvenilirlik Çalışması
ULAŞ H., ALPTEKİN K., Özbay D., Çakır E., Tümüklü M., Şimşek S., et al.
Klinik Psikiyatri , vol.10, pp.77-85, 2007 (Peer-Reviewed Journal)
2007
2007162. Düşünce ve Dil Ölçeğinin Türkçe formunun geçerlik ve güvenilirlik çalışması
ULAŞ H., ALPTEKİN K., Özbay D., AKDEDE B. B., Çakır E., Tümüklü M., et al.
KLINIK PSIKIYATRI DERGISI , vol.10, pp.77-85, 2007 (Peer-Reviewed Journal)
2006
2006163. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: Effects on cognition
Akdede B. B., ANIL YAĞCIOĞLU A. E., ALPTEKİN K., Turgut T. I., Tumuklu M., YAZICI M. K., et al.
JOURNAL OF CLINICAL PSYCHIATRY
, vol.67, no.12, pp.1912-1919, 2006 (SCI-Expanded)
2006
2006164. Assessment of quality of life with the WHOQOL-BREF in a group of Turkish psychiatric patients compared with diabetic and healthy subjects
Akvardar Y., Akdede B. B., Oezerdem A., Eser E., Topkaya S., ALPTEKİN K.
PSYCHIATRY AND CLINICAL NEUROSCIENCES
, vol.60, no.6, pp.693-699, 2006 (SCI-Expanded)
2006
2006165. Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population
Demiral Y., ERGÖR G., ÜNAL B., Semin S. S., Akvardar Y., Kivircik B. B., et al.
BMC PUBLIC HEALTH
, vol.6, 2006 (SCI-Expanded)
2006
2006166. Effects of an antistigma program on medical students' attitudes towards people with schizophrenia
Altindag A., Yanik M., Ucok A., ALPTEKİN K., Ozkan M. H.
PSYCHIATRY AND CLINICAL NEUROSCIENCES
, vol.60, no.3, pp.283-288, 2006 (SCI-Expanded)
2005
2005167. Basic standards for management of patients with common mental illnesses in primary care
Agius M., Biočina S. M., ALPTEKİN K., Rotstein V., Morselli P., Persaud A.
Psychiatria Danubina
, vol.17, no.3-4, pp.205-220, 2005 (Scopus)
2005
2005168. Basic standards for management of patients with serious mental illness in the community
Agius M., Martic Biočina S., ALPTEKİN K., Rotstein V., Morselli P., Persaud A.
Psychiatria Danubina
, vol.17, no.1-2, pp.42-57, 2005 (Scopus)
2005
2005169. Disability in schizophrenia: Clinical correlates and prediction over 1-year follow-up
ALPTEKİN K., Erkoc S., Gogus A., Kultur S., Mete L., Ucok A., et al.
PSYCHIATRY RESEARCH
, vol.135, no.2, pp.103-111, 2005 (SCI-Expanded)
2005
2005170. Quality of life in patients with obsessive-compulsive disorder: Relations with cognitive functions and clinical symptoms
Akdede B. B., ALPTEKİN K., Akvardar Y., Kitis A.
TURK PSIKIYATRI DERGISI
, vol.16, no.1, pp.13-19, 2005 (SSCI)
2005
2005171. Effects of quetiapine on cognitive functions in schizophrenia
Akdede B. B., ALPTEKİN K., Kitis A., Arkar H., Akvardar Y.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
, vol.29, no.2, pp.233-238, 2005 (SCI-Expanded)
2005
2005172. Is quality of life associated with cognitive impairment in schizophrenia?
ALPTEKİN K., Akvardar Y., Akdede B. B., Dumlu K., Isik D., PİRİNÇÇİ F., et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
, vol.29, no.2, pp.239-244, 2005 (SCI-Expanded)
2005
2005173. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safety
ANIL YAĞCIOĞLU A. E., Akdede B. B., Turgut T., Tumuklu M., YAZICI M. K., ALPTEKİN K., et al.
JOURNAL OF CLINICAL PSYCHIATRY
, vol.66, no.1, pp.63-72, 2005 (SCI-Expanded)
2005
2005174. A right orbitofrontal region and OCD symptoms: a case report - Invited comment
ALPTEKİN K.
ACTA PSYCHIATRICA SCANDINAVICA
, vol.111, no.1, pp.76-77, 2005 (SCI-Expanded)
2004
2004175. GENÇLERDE ŞİZOFRENİYİ DAMGALAMA DÜZEYİ
AKDEDE B. B., ALPTEKİN K., TOPKAYA Ş., GÜNGÖR B., NAZLI E., ÖZSİN E., et al.
Yeni Symposium , vol.42, no.3, pp.113-117, 2004 (Peer-Reviewed Journal)
2004
2004176. The Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study: Baseline clinical and functional characteristics and antipsychotic use patterns in Turkey
Şaylan M., ALPTEKİN K., Akdemir A., Tetik E., Korb F. A.
Klinik Psikofarmakoloji Bulteni
, vol.14, no.3, pp.132-142, 2004 (Scopus)
2004
2004177. Cognitive impairment and antipsychotic treatment in schizophrenia Şizofrenide bilişsel işlev bozukluklari ve antipsikotik tedavi
AKDEDE B. B., ALPTEKİN K.
Klinik Psikofarmakoloji Bulteni
, vol.14, no.3, pp.178-184, 2004 (Scopus)
2004
2004178. Quality of life assessment in Turkish patients with schizophrenia and their relatives
ALPTEKİN K., Akdede B. B., Akvardar Y., Celikgun S., Dilsen N., Durak G., et al.
PSYCHOLOGICAL REPORTS
, vol.95, no.1, pp.197-206, 2004 (SSCI)
2004
2004179. Quality of life and disability: Towards an integrative model in mental health care
Akvardar Y., ALPTEKİN K., ELBİ H., Fidaner C., Ozerdem A., Ustun B.
EUROPEAN PSYCHIATRY
, vol.19, 2004 (SCI-Expanded)
2004
2004180. Glass-ceramic glazes in the CaO-SiO2 system
ALPTEKİN K., Kara F.
EURO CERAMICS VIII, PTS 1-3
, vol.264-268, pp.1709-1712, 2004 (SCI-Expanded)
2004
2004181. Aging and schizophrenia: the relation of age to clinical symptoms and cognitive functions in schizophrenia Sizofreni ve Yaşlanma: Sizofrenide Klinik Belirtilerin ve Bilişsel Işlevlerin Yaşla Ilişkisi.
Alptekin K., B Kivircik Akdede B., Kitiş A., Akvardar Y., Ulaş H., Orhan Z.
Türk psikiyatri dergisi = Turkish journal of psychiatry
, vol.15, no.2, pp.91-97, 2004 (Scopus)
2004
2004182. Utilization of the auditory consonant trigram test to screen for cognitive impairment in patients with multiple sclerosis: comparison with the paced auditory serial addition test
Ozakbas S., Ormeci B., Akdede B. B., ALPTEKİN K., Idiman E.
MULTIPLE SCLEROSIS
, vol.10, no.6, pp.686-689, 2004 (SCI-Expanded)
2004
2004183. Substance Use among Patients with Schizophrenia in a University Hospital
AKVARDAR Y., Tümüklü M., AKDEDE B. B., ULAŞ H., Kitiş A., ALPTEKİN K.
Klinik Psikofarmakoloji Bülteni,
, vol.14, pp.191-197, 2004 (Scopus)
2003
2003184. Autoerythrocyte sensitization (Gardner-Diamond) syndrome mimicking compartment syndrome
Karatosun V. A., Satoglu S., Gunal I., ALPTEKİN K.
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
, vol.123, no.7, pp.370-371, 2003 (SCI-Expanded)
2003
2003185. Effect of clozapine on serum leptin, insulin levels, and body weight and composition in patients with schizophrenia
Kivircik B. B., ALPTEKİN K., Caliskan S., Comlekci A., Oruk G., Tumuklu M., et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
, vol.27, no.5, pp.795-799, 2003 (SCI-Expanded)
2003
2003186. The rights and wrongs in acute agitation treatment: A guideline for the antiagitation treatment in emergency settings Akut ajitasyon tedavisinde doǧrular ve yanlişlar: Acil servis antiajitasyon tedavi rehberi
Yildiz A., ALPTEKİN K.
Klinik Psikofarmakoloji Bulteni
, vol.13, no.1, pp.30-36, 2003 (Scopus)
2003
2003187. Event-related potentials and neuropsychological tests in obsessive-compulsive disorder
Kivircik B. B., Yener G., ALPTEKİN K., Aydin H.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
, vol.27, no.4, pp.601-606, 2003 (SCI-Expanded)
2002
2002188. Comorbid panic symptoms and relation with clinical correlates in schizophrenia
ALPTEKİN K., Ulas H., Kyvyrcyk B., Tumuklu M., Akvardar Y., Kitip A.
EUROPEAN NEUROPSYCHOPHARMACOLOGY
, vol.12, 2002 (SCI-Expanded)
2002
2002189. Effect of clozapine treatment on serum leptin and insulin levels and body composition
Kyvyrcyk B., ALPTEKİN K., Calyskan S., Comlekci A., Oruk G., Tumuklu M., et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY
, vol.12, 2002 (SCI-Expanded)
2002
2002190. Quetiapine-induced improvement of tardive dyskinesia in three patients with schizophrenia
ALPTEKİN K., Kivircik B. B.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
, vol.17, no.5, pp.263-264, 2002 (SCI-Expanded)
2002
2002191. A multi-center 1-year follow-up study of patients with schizophrenia in Turkey: Relapse and its predictors
Ucok A., Kultur S., ALPTEKİN K., Erkoc S., Gogus A., Mete L., et al.
SCHIZOPHRENIA RESEARCH
, vol.53, no.3, pp.251, 2002 (SCI-Expanded)
2002
2002192. Co-morbid substance abuse and smoking in Turkish patients with schizophrenia
ALPTEKİN K., Erkoc S., Gogus A., Kultur S., Mete L., Ucok A., et al.
SCHIZOPHRENIA RESEARCH
, vol.53, no.3, pp.224, 2002 (SCI-Expanded)
2002
2002193. Disability in schizophrenia: A multicenter study of 1-year follow-up of patients with schizophrenia in Turkey
ALPTEKİN K., Erkoc S., Gogus A., Kultur S., Mete L., Ucok A., et al.
SCHIZOPHRENIA RESEARCH
, vol.53, no.3, pp.261, 2002 (SCI-Expanded)
2002
2002194. Relation of family history of schizophrenia with clinical variables in patients with schizophrenia
Ucok A., Kultur S., ALPTEKİN K., Erkoc S., Gogus A., Mete L., et al.
SCHIZOPHRENIA RESEARCH
, vol.53, no.3, pp.81, 2002 (SCI-Expanded)
2001
2001195. Tc-99m HMPAO brain perfusion SPECT in drug-free obsessive-compulsive patients without depression
ALPTEKİN K., Degirmenci B., Kivircik B. B., Durak H., Yemez B., Derebek E., et al.
PSYCHIATRY RESEARCH-NEUROIMAGING
, vol.107, no.1, pp.51-56, 2001 (SCI-Expanded)
2000
2000196. Event-related potentials and neuropsychological tests in obsessive-compulsive disorder
Kivircik B. B., Yener G., ALPTEKİN K., Elcin O., Aydin H.
EUROPEAN PSYCHIATRY
, vol.15, 2000 (SCI-Expanded)
1998
1998197. Parkinson Hastalığında Depresyon
GENÇ Ş., KIVICIK B. B., ALPTEKİN K., YENER G., FADILOĞLU Ş.
Parkinson Hastalığı ve Hareket Bozuklukları Dergisi , vol.1, no.1, pp.8-11, 1998 (Peer-Reviewed Journal)
1995
1995198. Senile dementia of Lewy body type: A case report LEWY CISMI TIP YASLILIK BUNAMASI: OLGU SUNUMU
ALPTEKİN K., YENER G.
Noropsikiyatri Arsivi
, vol.32, no.4, pp.205-208, 1995 (Scopus)
1995
1995199. Migrenli Hastalarda Ruhsal Belirti Dağılımı
AKHAN G., ALPTEKİN K., Bayburtluoğlu T.
Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi , pp.1-4, 1995 (Peer-Reviewed Journal)
Papers Presented at Peer-Reviewed Scientific Conferences
2023
20231. Elevated resting-state EEG gamma-band power in schizophrenia
Akgül Ö., Fide E., Özel F., Alptekin K., Bora İ. E., Akdede B. B., et al.
36th ECNP Congress, Barcelona, Spain, 7 - 10 October 2023, vol.2, pp.32, (Summary Text)
2023
20232. Relation between Negative Symptoms and Core Stability as an Indicator of Functional Exercise Capacity in Schizophrenia
Hoşgelen E. I., BOZBIYIK N., AKGÜL Ö., ŞİMŞEK F., GELECEK N., ALPTEKİN K.
31st European Congress of Psychiatry, 25 - 28 March 2023, (Summary Text)
2022
20223. ŞIZOFRENI TANISI ALMIŞ BIREYLERDE KOR STABILIZASYONUNUN BILIŞSEL IŞLEVLERLE ILIŞKISI
BOZBIYIK N., HOŞGELEN E. I., ŞİMŞEK F., ALPTEKİN K., GELECEK N.
2. Uluslararası Gazi Sağlık Bilimleri Kongresi, 15 - 17 December 2022, (Summary Text)
2022
20224. TOPIC MAINTENANCE IN SCHIZOPHRENIA
Özcan Vural A., Kuruoğlu G., Alptekin K.
XVII-th International Scientific and Practical Conference “Psycholinguistics in a Modern World – 2022”, Kyyiv, Ukraine, 15 November 2022, (Full Text)
2022
20225. SOSYAL ÇEVRE PSİKOTİK YAŞANTILARI NASIL ETKİLİYOR?
ERGÜL ARSLAN C., Drukke M., BİNBAY İ. T., KIRLI U., ELBİ H., ALPTEKİN K., et al.
58. ULUSAL PSİKİYATRİ KONGRESİ, İzmir, Turkey, 19 - 23 October 2022, (Summary Text)
2022
20226. COVID-19 pandemisi psikotik bozukluk hastalarını nasıl etkiledi? Depresyon dönemi umutsuzluk ve çaresizlik ile ilişkili miydi?
Temizelliler Z., Tüzün Y. C., Binbay İ. T., Akdede B. B., Alptekin K.
58. Ulusal Psikiyatri Kongresi, İzmir, Turkey, 19 - 23 October 2022, (Unpublished)
2022
20227. COVID-19 pandemisi psikotik bozukluk hastalarını nasıl etkiledi? Özkıyım düşünceleri ve girişimi
Tüzün Y. C., Temizelliler Z., Binbay İ. T., Akdede B. B., Alptekin K.
58. Ulusal Psikiyatri Kongresi, İzmir, Turkey, 19 - 23 October 2022, (Unpublished)
2022
20228. TRANSDIYAGNOSTIK BIR SIZOFRENI SPEKTRUM BOZUKLUGU VE BIPOLAR BOZUKLUGU ÖRNEKLEMINDE BILISSEL ALT GRUPLARIN NÖROANATOMIK ÖZELLIKLERI
Bora İ. E., Verim B., Demirlek C., Zorlu N., Ceylan D., Alptekin K., et al.
58. Ulusal Psikiyatri Kongresi, İzmir, Turkey, 19 - 23 October 2022, pp.1, (Summary Text)
2022
20229. A Six-year Follow-up Study in a Community-based Population: Is Neighbourhood-level Social Capital Associated with the Risk of Emergence and Persistence of Psychotic Experiences and Transition to Psychotic Disorder?
Ergül Arslan C., Binbay İ. T., Drukker M., Kırlı U., Elbi H., Alptekin K., et al.
The 7th Biennial Schizophrenia International Research Society Conference, Florence, Italy, 6 - 10 April 2022, pp.1-2, (Summary Text)
2022
202210. Nearly Half of Incident Psychotic Disorders over Six Years is Not Attributable to Preceding Positive Psychotic Experiences: A Prospective Study in a Representative General Population
Kırlı U., Binbay İ. T., Alptekin K., Elbi H., Van Os J.
The 7th Biennial Schizophrenia International Research Society Conference, Florence, Italy, 6 - 10 April 2022, pp.1-2, (Summary Text)
2021
202111. Sigara Kullanımı Psikotik Yaşantıların Kalıcı Hale Gelmesi ve Psikotik Bozukluğa İlerlemesi ile İlişkili Midir?
GÜVERCİN E., KIRLI U., BİNBAY İ. T., ALPTEKİN K., ELBİ H.
57. Ulusal Psikiyatri Kongresi, Ankara, Turkey, 20 - 24 October 2021, vol.32, pp.19, (Summary Text)
2021
202112. Sigara kullanımı psikotik yaşantıların kalıcı hale gelmesi ve psikotik bozukluğa ilerlemesi ile ilişkili midir?
Güvercin E., Kırlı U., Binbay İ. T., Alptekin K., Elbi H.
57. Ulusal Psikiyatri Kongresi, Ankara, Turkey, 20 - 24 October 2021, vol.32, pp.19, (Summary Text)
2021
202113. Şizofreni Tanılı Bireylerin Çalışma Yaşamına İlişkin Görüşleri: Kalitatif Çalışma
ÇETİNKAYA DUMAN Z., TUNCER G. Z., SARI A., ALPTEKİN K.
XI. Uluslararası X. Ulusal Psikiyatri Hemşireliği Kongresi, 20 October 2021, (Summary Text)
2021
202114. Reward processing related theta oscillations in schizophrenia
FİDE E., AKGÜL Ö., ÖZEL F., ALPTEKİN K., BORA İ. E., AKDEDE B. B., et al.
FENS REGIONAL MEETING 2021, Poland, 25 August 2021, (Summary Text)
2021
202115. REWARD PROCESSING RELATED GAMMA OSCILLATIONS IN SCHIZOPHRENIA
AKGÜL Ö., FİDE E., ÖZEL F., ALPTEKİN K., BORA İ. E., AKDEDE B. B., et al.
2021 Congress of the Schizophrenia International Research Society, FLORANSA, Italy, 17 April 2021, (Summary Text)
2020
202016. Sanal Gerçeklik Yoluyla Bilişsel Egzersizin Hafif Kognitif Bozukluk Olgularında Etkinliğinin EEG ile Değerlendirilmesi : Ön Sonuçlar
KARTELLİ F., ALPTEKİN K., BERGER M., YENER G., HOŞGELEN E. I.
18.ULUSAL SİNİRBİLİM KONGRESİ, Ankara, Turkey, 06 November 2020, vol.1, pp.125-126, (Full Text)
2020
202017. S49. THE RELATION BETWEEN PROCESSING SPEED AND USAGE OF MOBILE APPLICATIONS IN PATIENTS WITH SCHIZOPHRENIA
Hoşgelen E. I., AKGÜL Ö., AKDEDE B. B., ALPTEKİN K.
2020 Congress of the Schizophrenia International Research Society, 4 - 08 August 2020, (Summary Text)
2020
202018. VR A REAL ENVİRONMENT BASED VİRTUAL REALTY PSYCOSOCİAL TREATMEN MAY HELP PATİENS WİTH SCHP TO INCREAS SOCIAL FUNCTIONİNG
HOŞGELEN E. I., KARTELLİ F., ALPTEKİN K.
SIRS 2020, floransa, Italy, 4 - 08 April 2020, (Full Text)
2020
202019. M222. SURVEY RESULTS FROM TURKEY: KNOWLEDGE ABOUT SCHIZOPHRENIA, PUBLIC STIGMA AND DISCRIMINATION BECAUSE OF SCHIZOPHRENIA
SOYGÜR A. H., ALPTEKİN K., Yıldız M., Penn Ç., AVCIOĞLU M. M., ÜÇOK V. A.
7th Biennial Schizophrenia International Research Society Conference, Italy, 04 April 2020, (Full Text)
2020
202020. THE RELATION BETWEEN PROCESSING SPEED AND USAGE OF MOBILE APPLICATIONS IN PATIENTS WITH SCHIZOPHRENIA
Hosgelen E. I., Akgul O., AKDEDE B. B., ALPTEKİN K.
Congress of the Schizophrenia-International-Research-Society (SRIS), Florence, Italy, 4 - 08 April 2020, vol.46, (Summary Text)
2020
202021. A REAL ENVIRONMENT BASED VIRTUAL REALITY PSYCHOSOCIAL TREATMENT MAY HELP PATIENTS WITH SCHIZOPHRENIA TO INCREASE SOCIAL FUNCTIONING: A PRELIMINARY STUDY
Hosgelen E. I., KARTELLİ F., Berger M., Erinc S., Yerlikaya D., Ozbek Y., et al.
Congress of the Schizophrenia-International-Research-Society (SRIS), Florence, Italy, 4 - 08 April 2020, vol.46, (Summary Text)
2020
202022. A REAL ENVIRONMENT BASED VIRTUAL REALITY APPLICATION TO IMPROVE PHYSICAL HEALTH OF PATIENTS WITH SCHIZOPHRENIA
ALPTEKİN K., KARTELLİ F., Berger M., Hosgelen E. I., Erinc S., Yerlikaya D., et al.
Congress of the Schizophrenia-International-Research-Society (SRIS), Florence, Italy, 4 - 08 April 2020, vol.46, (Summary Text)
2020
202023. A NEW ASSESSMENT TOOL FOR FORMAL THOUGHT DISORDER IN SCHIZOPHRENIA: DOKUZ EYLUL THOUGHT DISORDER SCALE
Yalincetin B., Bora E., AKDEDE B. B., ALPTEKİN K.
Congress of the Schizophrenia-International-Research-Society (SRIS), Florence, Italy, 4 - 08 April 2020, vol.46, (Summary Text)
2020
202024. PREVELANCE USE OF TECHNOLOGICAL DEVICES AND INTERNET AMONG PATIENTS DIAGNOSED WITH SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER
Hosgelen E. I., AKDEDE B. B., ALPTEKİN K.
Congress of the Schizophrenia-International-Research-Society (SRIS), Florence, Italy, 4 - 08 April 2020, vol.46, (Summary Text)
2020
202025. PRAGMATIC INFERENCES IN SCHIZOPHRENIA: RELATIONSHIP WITH SYMPTOM DOMAINS, THEORY OF MIND AND NEUROCOGNITIVE FUNCTIONS
Yalincetin B., Bora E., AKDEDE B. B., ALPTEKİN K.
Congress of the Schizophrenia-International-Research-Society (SRIS), Florence, Italy, 4 - 08 April 2020, vol.46, (Summary Text)
2020
202026. SURVEY RESULTS FROM TURKEY: KNOWLEDGE ABOUT SCHIZOPHRENIA, PUBLIC STIGMA AND DISCRIMINATION BECAUSE OF SCHIZOPHRENIA
Haldun S., ALPTEKİN K., YILDIZ M., Penn C., Avcioglu M. M., Ucok A.
Congress of the Schizophrenia-International-Research-Society (SRIS), Florence, Italy, 4 - 08 April 2020, vol.46, (Summary Text)
2020
202027. CLINICAL AND DEVELOPMENTAL CHARACTERISTICS OF COGNITIVE SUBGROUPS IN A TRANSDIAGNOSTIC SAMPLE OF SCHIZOPHRENIA, SCHIZOAFFECTIVE DISORDER AND BIPOLAR DISORDER
Bora E., Verim B., Akgul O., Ildiz A., ALPTEKİN K., Ozerdem A., et al.
Congress of the Schizophrenia-International-Research-Society (SRIS), Florence, Italy, 4 - 08 April 2020, vol.46, (Summary Text)
2020
202028. P.334 An event-related potential study of reward processing in subjects with schizophrenia and healthy controls
AKGÜL Ö., Fide E., ÖZEL F., ALPTEKİN K., YENER G., BORA İ. E., et al.
ECNP Workshop for Early Career Scientists in Europe, 5 - 08 March 2020, (Summary Text)
2020
202029. An event-related potential study of reward processing in subjects with schizophrenia and healthy controls
Akgul O., Fide E., Ozel F., ALPTEKİN K., Yener G., BORA İ. E., et al.
ECNP Workshop on Junior Scientists in Europe, Nice, France, 5 - 08 March 2020, (Summary Text)
2018
201830. The relationship between obesity and response inhibition in schizophrenia-bipolar continuum
BORA İ. E., VERİM B., AKGÜL Ö., CEYLAN TUFAN ÖZALP D., ALPTEKİN K., ÖZERDEM A., et al.
31st ECNP Congress, Spain, 6 - 09 October 2018, (Summary Text)
2019
201931. Arilai: a naturalistic open-label study of aripiprazole long acting injectable efficacy on functioning and quality of life in schizophrenia patients
ALPTEKİN K., ANIL YAĞCIOĞLU A. E., EKER S. S., Yıldız M., Kaymak Ulusoy S., TAMAM L., et al.
32nd ECNP, Kopenhag, Denmark, 7 - 19 September 2019, (Summary Text)
2019
201932. Does (g) Factor Predict Theory of Mind Abilities in Schizophrenia?”
Akgül Ö., verim b., AKDEDE B. B., ALPTEKİN K., BORA İ. E.
XVI European Congress of Psychology, Moskva, Russia, 2 - 05 July 2019, vol.1, pp.760, (Summary Text)
2018
201833. Şizofrenide Zihin Kuramı İle Nörokognitif İşlevler Arasındaki İlişki
AKGÜL Ö., VERİM B., BORA İ. E., ALPTEKİN K., AKDEDE B. B.
20. Ulusal Psikoloji Kongresi, Turkey, 15 - 17 November 2018, (Summary Text)
2018
201834. Şizofreni Hastalarının Etkilenmemiş Birinci Derece Akrabalarında Minör Fiziksel Anomaliler: Bir Meta Analiz Çalışması
AKGÜL Ö., BORA İ. E., AKDEDE B. B., ALPTEKİN K.
54. Ulusal Psikiyatri Kongresi, Turkey, 2 - 06 October 2018, (Summary Text)
2018
201835. RELATION BETWEEN EARLY-ONSET PSYCHOSIS AND FORMAL THOUGHT DISORDER IN SCHIZOPHRENIA
ALPTEKİN K., Altinok S., Ulas H., Degirmencioglu B., Akded B.
6th Biennial Conference of the Schizophrenia-International-Research-Society (SIRS), Florence, Italy, 4 - 08 April 2018, vol.44, (Summary Text)
2018
201836. NEUROCOGNITIVE FUNCTIONING IN SCHIZOPHRENIA AND BIPOLAR DISORDER DURING THE REMISSION AND THE PSYCHOTIC STATES
Ceylan D., AKDEDE B. B., BORA İ. E., HIDIROĞLU ONGUN C., Tunca Z., ALPTEKİN K., et al.
6th Biennial Conference of the Schizophrenia-International-Research-Society (SIRS), Florence, Italy, 4 - 08 April 2018, vol.44, (Summary Text)
2018
201837. A META-ANALYSIS OF MINOR PHYSICAL ANOMALIES IN FIRST-DEGREE UNAFFECTED RELATIVES OF PATIENTS WITH SCHIZOPHRENIA
Akgul O., BORA İ. E., AKDEDE B. B., ALPTEKİN K.
6th Biennial Conference of the Schizophrenia-International-Research-Society (SIRS), Florence, Italy, 4 - 08 April 2018, vol.44, (Summary Text)
2017
201738. Bipolar bozukluğun ve şizofreninin remisyon ve psikotik belirtilidönemlerindeki hastaların bilişsel işlevler açısından karşılaştırılması
CEYLAN TUFAN ÖZALP D., AKDEDE B. B., BORA E., HIDIROĞLU ONGUN C., TUNCA Z., ALPTEKİN K., et al.
53. ULUSAL PSİKİYATRİ KONGRESİ, Bursa, Turkey, 3 - 07 October 2017, (Summary Text)
2017
201739. Neurocognitive functions in remission vs. psychotic states: a comparative study between bipolar disorder and schizophrenia
CEYLAN TUFAN ÖZALP D., AKDEDE B. B., BORA E., HIDIROĞLU ONGUN C., TUNCA Z., ALPTEKİN K., et al.
30th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Paris, France, 2 - 05 September 2017, vol.27, (Summary Text)
2017
201740. Neurocognitive functions in remission vs. psychotic states: a comparative study between bipolar disorder and schizophrenia
Ceylan D., Akdede B. B., BORA İ. E., Hidiroglu C., Tunca Z., ALPTEKİN K., et al.
30th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Paris, France, 2 - 05 September 2017, vol.27, (Summary Text)
2015
201541. ARE COMT-VAL158MET AND BDNF-VAL66MET POLYMORPHISMS ASSOCIATED WITH PSYCHOTIC EXPERIENCES AND CLINICAL PSYCHOSIS OUTCOME? EVIDENCE FROM A PROSPECTIVE POPULATION-BASED COHORT, 2008-2015
KIRLI U., ELBİ H., Binbay T., ALPTEKİN K., KAYAHAN B., Zagli N., et al.
23rd Annual World Congress of Psychiatric Genetics (WCPG), Toronto, Canada, 16 - 20 October 2015, vol.27, (Summary Text)
2015
201542. EXTENDED PSYCHOSIS PHENOTYPE AND GENE ENVIRONMENT INTERACTIONS: A FOLLOW-UP STUDY ON A LARGE COMMUNITY BASED POPULATION
ELBİ H., KIRLI U., Binbay T., ALPTEKİN K., KAYAHAN B., Zagli N., et al.
23rd Annual World Congress of Psychiatric Genetics (WCPG), Toronto, Canada, 16 - 20 October 2015, vol.27, (Summary Text)
2017
201743. Şizofrenide Klinik Özellikler ile Zihin Kuramı, Empati ve 2D:4D İlişkili mi?
AKGÜL Ö., KÜÇÜKÇOBAN O., BİNBAY İ. T., BORA İ. E., ALPTEKİN K., AKDEDE B. B.
IV. Deneysel-Bilişsel Psikoloji Sempozyumu, Turkey, 14 - 15 September 2017
2017
201744. Analyzing The Relationship Between Liability To Psychosis And Telomere Dysfunction: A Sib-pair Study
ÇEVİK B., MANÇE ÇALIŞIR Ö., SIRMATEL B., ATBAŞOĞLU E. C., SAKA M. C., ALPTEKİN K., et al.
Erciyes Medical Genetics Days, Kayseri, Turkey, 11 - 13 May 2017, vol.39, pp.60, (Summary Text)
2017
201745. Şizofrenide 2D:4D ile Sosyal Kognisyon
AKGÜL Ö., KÜÇÜKÇOBAN O., BİNBAY İ. T., ALPTEKİN K., AKDEDE B. B.
21. Yıllık Toplantı- Klinik Eğitim Sempozyumu, Turkey, 19 - 22 April 2017, (Summary Text)
2017
201746. Kavum Vergae ve şizofreni: 25 yıl boyunca tedavisiz kalmış bir olguda beyin görüntüleme bulguları ve klinik izlem.
SAĞIR B., BİNBAY İ. T., ÖZERDEM A., ALPTEKİN K., YALIN N., CEYLAN TUFAN ÖZALP D.
19. TPD Yıllık Toplantısı ve Klinik Eğitim Sempozyumu, Antalya, Turkey, 19 - 22 April 2017, vol.26, pp.47, (Summary Text)
2017
201747. ŞİZOFRENİ VE MYASTENİA GRAVİS EŞ TANILIBİR OLGUDA IVIG TEDAVİSİ İLE PSİKOTİKBELİRTİLERİN YATIŞMASI
ÖZEL F., DİREK N., ALPTEKİN K., ÖZERDEM A.
21. TPD YILLIK TOPLANTISI VE KLİNİK EĞİTİM SEMPOZYUMU, Turkey, 19 - 22 April 2017, (Summary Text)
2017
201748. FORMAL THOUGHT DISORDER IN SCHIZOPHRENIA AND BIPOLAR DISORDER: A SYSTEMATIC REVIEW AND META-ANALYSIS
ALPTEKİN K., Yalincetin B., Bora E., AKDEDE B. B.
16th International Congress on Schizophrenia Research (ICOSR), California, United States Of America, 24 - 28 March 2017, vol.43, (Summary Text)
2016
201649. COMT val158met ve BDNF val66met polimorfizmlerinin geniş psikoz fenotipi ile ilişkisi
BİNBAY İ. T., MISIR E., KIRLI U., ELBİ H., KAYAHAN B., ONAY H., et al.
52. Ulusal Psikiyatri Kongresi, Antalya, Turkey, 16 - 20 November 2016, vol.27, pp.3-5, (Summary Text)
2016
201650. Şizofrenide Zihin Kuramı ile Nörobilişsel İşlevlerin İlişkisi
AKGÜL Ö., KÜÇÜKÇOBAN O., ALPTEKİN K., AKDEDE B. B.
14. Ulusal Sinirbilim Kongresi, Turkey, 26 - 29 May 2016, (Summary Text)
2016
201651. lower frequency of metabolic syndrome predicted by schizotypal trai in discordant siblings of patents with schizophrenia
Atbaşoğlu C., GÜMÜŞ AKAY G., SAKA M. C., Gülöksüz S., ÜÇOK V. A., ALPTEKİN K., et al.
5th biennial SIRS conference, 2 - 06 April 2016
2016
201652. Exploring the impact of catechol O methyltransferase COMT and brain derived neurotrophic factor BDNF polymorphisms on association between psychotic experiences and depression suicidal ideation in a six year follow up of general population based sample
KIRLI U., BİNBAY İ. T., ELBİ H., ALPTEKİN K.
The 5th Biennial Conference Schizophrenia International Research Society (SIRS 2016), Florence, Italy, 2 - 06 April 2016, (Summary Text)
2016
201653. Exploring the Effect of COMT and BDNF Polymorphisms on Association between Psychotic Experiences and Depression Suicidal Ideation in a Six Year Follow Up of General Population Based Sample
BİNBAY İ. T., KIRLI U., ELBİ H., KAYAHAN B., ONAY H., ÖZKINAY F., et al.
5th Schizophrenia International Research Society Conference, 2 - 04 April 2016, (Summary Text)
2016
201654. The Relation between Childhood Trauma History and Psychotic Symptoms in Patients with First Episode Psychosis
AYER A., AYDINLI E., ALPTEKİN K.
5th Schizophrenia International Research Society Conference, 2 - 04 April 2016, (Summary Text)
2016
201655. Lower frequency of metabolic syndrome predicted by schizotypal traits in discordant siblings of patients with schizophrenia
ATBAŞOĞLU C., AKAY G. G., SAKA M. C., GÜLÖKSÜZ S., ÜÇOK V. A., ALPTEKİN K., et al.
5th Schizophrenia International Research Society Conference, 2 - 04 April 2016, (Summary Text)
2016
201656. Effect of Wider Social Environment on Relapses in Schizophrenia A Six Year Follow Up Study
ÜNAL B., BİNBAY İ. T., AZ M., ULAŞ H., ALPTEKİN K., AKDEDE B. B.
5th Schizophrenia International Research Society Conference, 2 - 04 April 2016, (Summary Text)
2016
201657. Socio Demographic and Clinical Characteristics in First Episode Psychosis
AYER A., AYDINLI E., ALPTEKİN K.
5th Schizophrenia International Research Society Conference, 2 - 04 April 2016, (Summary Text)
2016
201658. The Relationship between Theory of Mind and Thought Language Disorder in Schizophrenia
GÜNEYER D., KÜÇÜKÇOBAN O., ULAŞ H., BİNBAY İ. T., ALPTEKİN K., AKDEDE B. B.
5th Schizophrenia International Research Society Conference, 2 - 04 April 2016, (Summary Text)
2016
201659. The relation of schizotypy and cognition with theory of mind in first degree relatives of patients with diagnosis of schizophrenia
KÜÇÜKÇOBAN O., GÜNEYER D., YURDAKUL A., AKGÜL Ö., DİRİÖZ M., BİNBAY İ. T., et al.
5th Biennial Schizophrenia International Research Society Conference, npj Schizophr, Floransa, Italy, 2 - 06 April 2016, vol.2, pp.38, (Summary Text)
2016
201660. Conversion from psychosis like experiences in the community to not only psychotic disorders but also to depression and anxiety disorders six years follow up study in a community based population
KIRLI U., BİNBAY İ. T., ELBİ H., KAYAHAN B., ONAY H., ÖZKINAY F. F., et al.
5th Biennial Schizophrenia International Research Society Conference, npj Schizophr, Floransa, Italy, 2 - 06 April 2016, vol.2, pp.12, (Summary Text)
2016
201661. The relation of thought disorders in schizophrenia with remission of symptoms and psychosocial improvement
YALINÇETİN B., ALPTEKİN K., VAR L., ULAŞ H., BİNBAY İ. T., AKDEDE B. B.
5th Biennial Schizophrenia International Research Society Conference, npj Schizophr, Floransa, Italy, 2 - 06 April 2016, vol.2, pp.94-95, (Summary Text)
2016
201662. What does 2D 4D tell us about social cognition
AKGÜL Ö., KÜÇÜKÇOBAN O., BİNBAY İ. T., ALPTEKİN K., AKDEDE B. B.
5th Biennial Schizophrenia International Research Society Conference, npj Schizophr, Floransa, Italy, 2 - 06 April 2016, vol.2, pp.34, (Summary Text)
2016
201663. Which Social Environment Is More Important In Persistence Of Psychotic Experiences Differential Impact of Neighborhood and Family Context In a Six Year Longitudinal Population Based Cohort
BİNBAY İ. T., KIRLI U., ELBİ H., KAYAHAN B., ONAY H., ÖZKINAY F. F., et al.
European Psychiatric Association (EPA 2016) , Madrid, Spain, 12 - 15 March 2016, vol.33, pp.202-203, (Summary Text)
2016
201664. Psychotic experiences alcohol cannabis abuse stressful events and familial risk is associated with onset of clinical psychosis Evidence from a 6 years longitudinal population based cohort
KIRLI U., BİNBAY İ. T., ELBİ H., KAYAHAN B., vanOs J., ONAY H., et al.
European Psychiatry 33: 260-261 European Psychiatric Association (EPA 2016) , Madrid, Spain, 12 - 15 March 2016, (Summary Text)
2016
201665. Cognitive dysfunctions in first episode pychosis
ALPTEKİN K., AYDINLI E., AYER A., YALINÇETİN B., ULAŞ H., BİNBAY İ. T., et al.
24rd European Congress of Psychiatry, 12 - 15 March 2016, (Summary Text)
2016
201666. A Six Year Longitudinal Population Based Cohort for the Extended Psychosis Phenotype An Epidemiological Study of the Gene Environment Interactions TürkSch European Psychiatry 33 284 285 Poster presentation
ALPTEKİN K., BİNBAY İ. T., KIRLI U., ELBİ H., KAYAHAN B., ONAY H., et al.
European Psychiatric Association EPA 2016, Madrid, Spain, 12 - 15 March 2016, vol.33, pp.284-285, (Summary Text)
2016
201667. Psychotic experiences alcohol cannabis abuse stressful events and familial risk is associated with onset of clinical psychosis Evidence from a 6 year longitudinal population based cohort
KIRLI U., BİNBAY İ. T., ELBİ H., KAYAHAN B., VAN OS J., ONAY H., et al.
24rd European Congress of Psychiatry, 12 - 15 March 2016, (Summary Text)
2016
201668. Psychotic experiences convert not only to psychotic disorders also to depression and anxiety disorders Evidence from a 6 years follow up of a large general population sample
KIRLI U., BİNBAY İ. T., ELBİ H., KAYAHAN B., vanOs J., ONAY H., et al.
Schizophrenia International Research Society (SIRS 2016). The 5th Biennial Conference, Florence, Italy, 12 - 15 March 2016, pp.12, (Summary Text)
2016
201669. A six year longitudinal population based cohort for the extended psychosis phenotype An epidemiological study of the gene environment interactions TürkSch
ALPTEKİN K., BİNBAY İ. T., KIRLI U., ELBİ H., KAYAHAN B., ONAY H., et al.
24rd European Congress of Psychiatry, 12 - 15 March 2016, (Summary Text)
2016
201670. Subthreshold Depression As A Predictor of Emergence and Persistence of Psychotic Experiences A Six Years Longitudinal Population Based Cohort
ELBİ H., BİNBAY İ. T., KIRLI U., KAYAHAN B., ONAY H., ÖZKINAY F. F., et al.
European Psychiatry 33: 268-269 (Poster presentation). European Psychiatric Association (EPA 2016) , Madrid-Ispanya, Madrid, Spain, 12 - 15 March 2016, vol.33, pp.268, (Summary Text)
2016
201671. Which social environment is more important in the persistence of psychotic experiences Differential impact of neighbourhood and family context in a six year longitudinal population based cohort
BİNBAY İ. T., KIRLI U., ELBİ H., KAYAHAN B., ONAY H., ÖZKINAY F. F., et al.
24th European congress of Psychiatry, Eur Psychiatry, Madrid, Spain, 12 - 15 March 2016, vol.33, pp.198, (Summary Text)
2016
201672. Subthreshold depression as a predictor of emergence and persistence of psychotic experiences A six year longitudinal population based cohort
ELBİ H., BİNBAY İ. T., KIRLI U., KAYAHAN B., ONAY H., ÖZKINAY F. F., et al.
24th European Congress of Psychiatry, Eur Psychiatry, Madrid, Spain, 12 - 15 March 2016, vol.33, pp.264, (Summary Text)
2016
201673. Quitting cannabis decreases but does not eliminate psychosis risk: evidence from a 7 years large populationbased cohort
Kirli U., Binbay T., ELBİ H., Kayahan B., Gokcelli D., ALPTEKİN K., et al.
ECNP Workshop for Junior Scientists in Europe, Nice, France, 17 - 20 March 2016, vol.26, (Summary Text)
2015
201574. Sistemik Lupus Eritematozusta Bir Manik Epizod Olgusu
MISIR E., TARGITAY B., ARAT H. E., BİNBAY İ. T., ALPTEKİN K.
51. Ulusal Psikiyatri Kongresi, Turk Psikiyatri Derg, Antalya, Turkey, 25 - 29 November 2015, vol.26, pp.63
2015
201575. Su91 Are COMT Val158Met and BDNF Val66Met Polymorphisms Associated with Psychotic Experiences and Clinical Psychosis Outcome Evidence from a Prospective Population based Cohort 2008 2015
KIRLI U., ELBİ H., BİNBAY İ. T., ALPTEKİN K., KAYAHAN B., Nesli Z., et al.
International Society of Psychiatric Genetics (ISPG) 23rd World Congress of Psychiatric Genetics, Toronto, Canada, 17 - 21 October 2015
2015
201576. Difficult to treat patients with schizophrenia case presentations
ALPTEKİN K.
9th International Congress: Optimization of Treatment in Psychiatry, 10 - 12 December 2015, (Summary Text)
2015
201577. 6 yıllık toplum tabanlı prospektif bir izlemde, psikotik yaşantıların, klinik psikoz gelişiminin ve ilişkili risk faktörlerinin uzunlamasına incelenmesi
KIRLI U., BİNBAY İ. T., ELBİ H., ALPTEKİN K., KAYAHAN B., KESKİN GÖKÇELLİ D.
Türkiye Psikiyatri Derneği (TPD) 51. Ulusal Psikiyatri Kongresi, Antalya, Turkey, 25 - 29 November 2015, vol.26, pp.4-5, (Summary Text)
2015
201578. Are COMT Val158Met and BDNF Val66Met Polymorphisms Associated with Psychotic Experiences and Clinical Psychosis Outcome Evidence from a Prospective Population Based Cohort 2008 2015
KIRLI U., ELBİ H., BİNBAY İ. T., ALPTEKİN K., KAYAHAN B., ZAĞLI N., et al.
23rd World Congress of Psychiatric Genetics, Eur Neuropsychopharmacol, Toronto, Canada, 16 - 20 October 2015, vol.25, pp.115-116
2015
201579. Şizofreni hastalarında bilişsel ve motor görevlerin dengeye etkisi pilot çalışma
YILDIRIM M., ELVAN A., ERCEGİL G., ŞİMŞEK İ. E., YAZGEÇ E., DEMİR Ş. S., et al.
51. Ulusal Psikiyatri Kongresi, Antalya, Turkey, 25 - 29 November 2015
2015
201580. ŞİZOFRENİ HASTALARINDA BİLİŞSEL VE MOTOR GÖREVLERİN DENGEYE ETKİSİ Pilot Çalışma
YILDIRIM M., ELVAN A., ERCEGİL G., ŞİMŞEK İ. E., YAZGEÇ E., DEMİR Ş. S., et al.
51. ULUSAL PSİYATRİ KONGRESİ, Antalya, Turkey, 25 - 29 November 2015, vol.26, pp.112
2015
201581. TurkSCH II 6 yıllık toplum tabanlı prospektif bir izlemde psikotik yaşantıların klinik psikoz gelişiminin ve ilişkili risk faktörlerinin uzunlamasına incelenmesi
KIRLI U., BİNBAY İ. T., ELBİ H., ALPTEKİN K., KAYAHAN B., KESKİN GÖKÇELLİ D.
51. Ulusal Psikiyatri Kongresi, Turkey, 25 - 29 November 2015
2015
201582. Şizofreni Tedavisinde Sorunlar ve Pratik Çözüm Önerileri
SOYGÜR H., ALPTEKİN K.
51. Ulusal Psikiyatri Kongresi, Turkey, 25 - 29 November 2015
2015
201583. Şizofreninin Geleceği
ALPTEKİN K.
51. Ulusal Psikiyatri Kongresi, Turkey, 25 - 29 November 2015
2015
201584. Geniş Psikoz Fenotipi Eşikaltı Yaşantılardan Psikotik Bozukluklara
ALPTEKİN K.
51. Ulusal Psikiyatri Kongresi, Turkey, 25 - 29 November 2015
2015
201585. Şizofreni ve Psikotik Bozukluklarda Tedavi Cevabının Öngörücüleri
ALPTEKİN K.
51. Ulusal Psikiyatri Kongresi, Turkey, 25 - 29 November 2015
2015
201586. İlk atak psikoz hastalarında nöropsikolojik değerlendirmeler
AYDINLI E., AYER A., ALPTEKİN K.
51. Ulusal Psikiyatri Kongresi, Turkey, 25 - 29 November 2015, (Summary Text)
2015
201587. Are BDNF Val66Met and COMT Val158Met polymorphisms associated with psychotic experiences and clinical psychotic outcome Evidence from a prospective population based cohort 2008 2015
ONAY H., KAYAHAN B., BİNBAY İ. T., ALPTEKİN K., ÖZKINAY F. F., ELBİ H.
2015 World Congress of Psychiatric Genetics; Toronto, Canada', 16 - 20 October 2015
2015
201588. Extended Psychosis Phenotype Gene Environment Interactions A Follow up Study on a Community Based Population
KIRLI U., ELBİ H., BİNBAY İ. T., ALPTEKİN K., KAYAHAN B., zağlı n., et al.
International Society of Psychiatric Genetics (ISPG) 23rd World Congress of Psychiatric Genetics, 16 - 20 October 2015
2015
201589. The effect of thought disorders on remission in schizophrenia
ALPTEKİN K., YALINÇETİN B., ULAŞ H., BİNBAY İ. T., AKDEDE B. B.
5th European Conference on Schizophrenia Research, Eur Arch Psychiatry Clin Neurosci, Berlin, Germany, 24 - 26 September 2015, vol.265, pp.99
2015
201590. First episode psychosis related to cognitive dysfunctions
ALPTEKİN K.
5th Biennial Cambridge International Conference on Mental Health 2015, 11 - 14 September 2015, (Summary Text)
2015
201591. The effect of thought disorders on remission of symptoms in schizophrenia
Yalincetin B., ALPTEKİN K., Ulas H., Binbay T., Akdede B. B.
28th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Amsterdam, Netherlands, 29 August - 01 September 2015, vol.25, (Summary Text)
2015
201592. The effect of thought disorders on psychosocial functioning in schizophrenia
Yalincetin B., Ulas H., Binbay T., Akdede B. B., ALPTEKİN K.
28th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Amsterdam, Netherlands, 29 August - 01 September 2015, vol.25, (Summary Text)
2015
201593. The effect of thought disorders on psychosocial funtioning in schizophrenia
BERNA Y., ULAŞ H., BİNBAY İ. T., AKDEDE B. B., ALPTEKİN K.
28TH ECNP CONGRESS, 29 - 31 August 2015
2015
201594. Kavum Vergae ve Şizofreni 25 Yıl Boyunca Tedavisiz Kalmış Bir Olguda Beyin Görüntüleme Bulguları ve Klinik İzlem
SAĞIR B., BİNBAY İ. T., ÖZERDEM A., ALPTEKİN K., YALIN N., CEYLAN D.
TPD 19. Yıllık Toplantısı ve Klinik Eğitim Sempozyumu, Turk Psikiyatri Derg, Antalya, Turkey, 6 - 09 May 2015, vol.26, pp.47
2015
201595. Şizofreni Hastalarında Fiziksel Egzersiz Beyin Yapılarını Nasıl Etkilemektedir Sistematik Bir Değerlendirme
ERCEGİL G., ALPTEKİN K.
12th International Cognitive Neuroscience Congress, İstanbul, Turkey, 14 - 17 May 2015
2015
201596. Effects physical exercise on brain structures amongschizophrenia patients an evaluation
ERCEGİL G., ALPTEKİN K.
13. ULUSAL SİNİRBİLİM KONGRESİ, Turkey, 29 April - 03 May 2015, vol.9, pp.1-69, (Full Text)
2015
201597. The Relation of Thought Language Disorders in Schizophrenia with Remission of Symptoms and Psychosocial Improvement
YALINÇETİN B., ALPTEKİN K., VAR L., BİNBAY İ. T., AKDEDE B. B.
23rd European Congress of Psychiatry (EPA), Viyana, Austria, 28 - 31 March 2015
2014
201498. Yeni Bir Sosyal ortama uyıum Süreci Psikotik Yaşantıları Tetikliyor mu Kehus P
MISIR E., ONRAT E., BİNBAY İ. T., ULAŞ H., AKDEDE B. B., ALPTEKİN K.
50. Ulusal Psikiyatri Kongresi, Turk Psikiyatri Derg, Antalya, Turkey, 12 November - 16 December 2014, vol.25, pp.175
2014
201499. An association study of RGS4 polymorphisms with clinical and neurocognitive profiles of schizophrenia patients
Can G., Gulsu E., Karad B. D., Topuzoglu A., ERESEN YAZICIOĞLU Ç., Akdede B., et al.
27th ECNP Congress, Berlin, Germany, 18 - 21 October 2014, vol.24, (Summary Text)
2014
2014100. Identification rate of Schizophrenia based on local brain volumes and dichotic listenning scores
KARABAY N., GÖKÇAY D., EKEN A., TURGUT U. O., ÖNİZ A., ALPTEKİN K., et al.
Organization for Human Brain Mapping 2014 Annual Meeting, Hamburg, Germany, 8 - 12 June 2014, (Summary Text)
2014
2014101. Objectives Design and Methodology of the TürkSch
BİNBAY İ. T., ALPTEKİN K., ELBİ H., KIRLI U., KAYAHAN B., ONAY H., et al.
17th EPA Section Epidemiology and Social Psychiatry Meeting, Ulm, Germany, 21 - 24 May 2014
2014
2014102. Epidemiology of Major Depressive Disorder in Izmir Turkey Prevalence Burden and Service Usage
TOPUZOĞLU A., BİNBAY İ. T., ALPTEKİN K., ELBİ H., AKSU TANIK F. B., ULAŞ H.
17th EPA Section Epidemiology and Social Psychiatry Meeting, Ulm, Germany, 21 - 24 May 2014
2014
2014103. Relation Between Psychotic like Experiences and major Depression in the Community Based Sample
TOPUZOĞLU A., BİNBAY İ. T., ELBİ H., ZAĞLI N., ONAY H., ÖZKINAY F. F., et al.
4th Biennial Schizophrenia International Research Conference, Schizophr Res, Floransa, Italy, 5 - 09 April 2014, vol.153, pp.374
2014
2014104. The Impact of Parantal Consanguinity on teh Extended Psychosis Phenotype
BİNBAY İ. T., ALPTEKİN K., ELBİ H., ULAŞ H., DRUKKER M., VAN OS J.
4th Biennial Schizophrenia International Research Conference, Schizophr Res, Floransa, Italy, 5 - 09 April 2014, vol.153, pp.297-298
2014
2014105. Familial liability the BDNF Val66Met polymorphism and psychotic like experiences
ALPTEKİN K., BİNBAY İ. T., ELBİ H., ONAY H., ÖZKINAY F. F., ZAĞLI N., et al.
17th EPA Section Epidemiology and Social Psychiatry Meeting, Ulm, Germany, 21 May - 24 April 2014
2014
2014106. Poster S136 RELATION OF RGS4 GENE WITH SCHIZOPHRENIA
Gülsu E., ERESEN YAZICIOĞLU Ç., KIZILDAĞ S., Değirmencioğlu B., TAŞLICA S., ALPTEKİN K.
the 4th Biennial Schizophrenia International Research Conference, Floransa, Italy, 5 - 09 April 2014, vol.153, pp.138
2014
2014107. One year Prevalence of Major Depressive Disorder and Related Socioeconomic Factors in Izmir City Center
BİNBAY İ. T., TOPUZOĞLU A., ELBİ H., ALPTEKİN K., ZAĞLI N., MISIR E., et al.
22nd European Congress of Psychiatry, Eur Psychiatry, Munich, Germany, 1 - 04 March 2014, vol.29, pp.1
2013
2013108. Low in prevalence high in burden Alcohol and substance abuse in Izmir Turkey
DAS H., BİNBAY İ. T., ALPTEKİN K., ULAŞ H., YÜRÜR Y., ELBİ H.
7th International Scientific Research and Training Conference, Wisla, Poland, 12 - 14 December 2013
2013
2013109. The Impact of Consanguinity on Risk of Extended Psychosis Phenotype
YÜRÜR Y., BİNBAY İ. T., ALPTEKİN K., ULAŞ H., DAS H., ELBİ H.
7th International Scientific Research and Training Conference, Wisla, Poland, 12 - 14 December 2013
2013
2013110. Early Age on Onset may Affect Dysfunctions in Thought Disorder in Patients with Schizophrenia
DAS H., YÜRÜR Y., YALINÇETİN B., SEVİLMİŞ Ş., VAR L., BİNBAY İ. T., et al.
Cambridge & Luton International Conference on Mental Health 2013, Psychiatria Danubina, Cambridge, Canada, 5 - 07 September 2013, vol.25, pp.388
2013
2013111. Relation between Emotion Recognition and Abstract Thinking in Schizophrenia
YÜRÜR Y., DAS H., YILDIRIM E., YALINÇETİN B., ŞİLAY S., ÖZGE K., et al.
Cambridge & Luton International Conference on Mental Health 2013, Psychiatria Danubina, Cambridge, Canada, 5 - 07 September 2013, vol.25, pp.388
2013
2013112. Sinop İlinde Tanımlı Bir Alanda Şizofreni Ve Psikotik Belirtili Bozuklukların Yaygınlığı Sağlık Kayıtlarına Dayalı Bir Araştırma Sinopsy
BİNBAY İ. T., ARIK BİNBAY D., ULAŞ H., AKDEDE B. B., ALPTEKİN K.
49. Ulusal Psikiyatri Kongresi, İzmir, Turkey, 24 - 28 September 2013
2013
2013113. İzmir İl Merkezinde Bir Yıllık DSM IV TR Majör Depresif Bozukluk Yaygınlığı
BİNBAY İ. T., TOPUZOĞLU A., ELBİ H., ALPTEKİN K., ZAĞLI N., MISIR E.
49. Ulusal Psikiyatri Kongresi, İzmir, Turkey, 24 - 28 September 2013
2013
2013114. Admission Based Prevalence of Schizophrenia Schizoaffective Disorder and Bipolar Affective Disorder in a Catchment Area in Sinop Turkey
BİNBAY İ. T., ARIK BİNBAY D., ULAŞ H., AKDEDE B. B., ALPTEKİN K.
14th International Congress of the International Federation of Psychiatric Epidemiology, Leipzig, Germany, 5 - 08 June 2013
2012
2012115. Şizofreni ve şizoaffektif bozukluk hastalarında çoklu antipsikotik tedavisinin etkileri
CEYLAN TUFAN ÖZALP D., YEŞİLYURT S., AKDEDE B. B., TOPUZOĞLU A., SAYIN Z., DİRİÖZ M., et al.
48. Ulusal Psikiyatri Kongresi, Bursa, Turkey, 9 - 13 October 2012, (Summary Text)
2012
2012116. The Global Alliance of Mental Illness Advocacy Networks (GAMIAN-Europe) pan European adherence to treatment
Montellano P., Arteel P., De Hert M., ALPTEKİN K., Gauci D.
25th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Vienna, Austria, 13 - 17 October 2012, vol.22, (Summary Text)
2012
2012117. Do attitudes towards medication adherence in schizophrenia vary between stakeholders? A comparison of survey results
Hargarter L., Emsley R., ALPTEKİN K., Canas F., Gorwood P., Naber D., et al.
25th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Vienna, Austria, 13 - 17 October 2012, vol.22, (Summary Text)
2012
2012118. Evidence that the wider social environment moderates the association between familial liability and psychosis spectrum outcome
BİNBAY İ. T., ELBİ H., ALPTEKİN K., DRUKKER M., VAN OS J.
EPA-EU GEI Conference, Maastricht, Netherlands, 13 - 16 June 2012
2012
2012119. Şizofreni hastalarında içselleştirilmiş damgalanma: içgörü ve tedaviye uyumla ilişkisi
YILDIRIM E., Sevilmiş Ş., Yalınçetin B., Aydınlı E., Kutay Ö., ALPTEKİN K.
17. Ulusal Psikoloji Kongresi, İstanbul, Turkey, 25 - 28 April 2012, (Summary Text)
2012
2012120. Change in psychopharmacotherapy of schizophrenia patients within a period of 10 years.
CEYLAN TUFAN ÖZALP D., AKTENER A. Y., AKDEDE B. B., ALPTEKİN K.
3rd Schizophrenia International Research Society Conference, Florence, Italy, 14 - 18 April 2012, vol.136, pp.170, (Summary Text)
2011
2011121. Şizofrenideki duygu tanıma bozukluklarının düşünce bozukluğu ile ilişkisi
YILDIRIM E., Yalınçetin B., Sevilmiş Ş., Kutay Ö., Akdede B. B., Ulaş H., et al.
47. Ulusal Psikiyatri Kongresi, Antalya, Turkey, 26 - 31 October 2011, (Summary Text)
2011
2011122. Şizofrenide düşünce-dil bozukluğunun negatif belirtiler ile ilişkisi
Yalınçetin B., Değirmencioğlu B., Sevilmiş Ş., YILDIRIM E., Ulaş H., POLAT S., et al.
47. Ulusal Psikiyatri Kongresi, Antalya, Turkey, 26 - 31 October 2011, (Summary Text)
2011
2011123. İnternet aracılığıyla paylaşılmış psikotik bozukluk
YALIN N., CEYLAN TUFAN ÖZALP D., AKDEDE B. B., ALPTEKİN K.
TPD 15. Yıllık Toplantı ve Klinik Eğitim Sempozyumu, Antalya, Turkey, 12 - 16 April 2011, (Summary Text)
2010
2010124. HIGH PREVALENCE OF PSYCHOSIS CONTINUUM IN A HIGHLY URBANIZED AREA OF TURKEY: TURKSCH STUDY
BİNBAY İ. T., ELBİ H., Aksu F., Oezkinay F., Oenay H., Drukker M., et al.
2nd Conference of the Schizophrenia-International-Research-Society (SIRS), Florence, Italy, 10 - 14 April 2010, vol.117, pp.435, (Summary Text)
2009
2009125. İzmir Kent Merkezinde Psikoz Sürekliliğinin Yaşamboyu Yaygınlığı ve İlişkili Olduğu Etkenler
BİNBAY İ. T., ELBİ H., ALPTEKİN K., ZAĞLI N., AKSU TANIK F. B., ONAY H.
45. Ulusal Psikiyatri Kongresi, Ankara, Turkey, 20 - 24 October 2009
2009
2009126. Türkiye de Psikotik Bozukluklar Epidemiyolojisi Yaygınlık Tahminleri ve Kurum Başvuruları Üzerine Sistematik Bir Gözden Geçirme
BİNBAY İ. T., ULAŞ H., ELBİ H., ALPTEKİN K.
45. Ulusal Psikiyatri Kongresi, Ankara, Turkey, 20 - 24 October 2009
2009
2009127. VOLUMETRIC EVALUATION IN SCHIZOPHRENIA
KARABAY N., Oniz A., MEN S., ALPTEKİN K., Ozgoren M.
49th Annual Meeting of the Society-for-Psychophysiological-Research, Berlin, Germany, 21 - 24 October 2009, vol.46, (Summary Text)
2009
2009128. NEUROTROPHIC FACTORS AND SCHIZOPHRENIA: RELATION TO COGNITION
AKDEDE B. B., ALPTEKİN K., Oguz M., Aykan S., Ulas H.
12th International Congress on Schizophrenia Research, California, United States Of America, 28 March - 01 April 2009, vol.35, pp.301, (Summary Text)
2009
2009129. MULTIBLOCK AUDITORY APPROACH IN SCHIZOPHRENIA PATIENTS
Ozgoren M., Oniz A., Taslica S., Aktener A., Akdede B., ALPTEKİN K.
12th International Congress on Schizophrenia Research, California, United States Of America, 28 March - 01 April 2009, vol.35, pp.59-60, (Summary Text)
2008
2008130. Expressions of mRNA for GDNF in schizophrenia
ALPTEKİN K., Aykan S., Akdede B. B. K., Ulas H., Aktener A., Can C., et al.
14th World Congress of Psychophysiology the Olympics of the Brain, St Petersburg, Russia, 8 - 13 September 2008, vol.69, pp.294, (Summary Text)
2008
2008131. Modified MMN and Dichotic Listening paradigm applied in schizophrenia patients
Oniz A., Ozgoren M., Taslica S., GÜDÜCÜ Ç., Aktener A., Akdede B., et al.
14th World Congress of Psychophysiology the Olympics of the Brain, St Petersburg, Russia, 8 - 13 September 2008, vol.69, pp.293-294, (Summary Text)
2007
2007132. Şizofreni Hastalarında Serum BDNF Düzeylerinin Klinik Belirtiler ve Bilişsel İşlevlerdeki Bozulmayla İlişkisi
AYKAN S., ALPTEKİN K., AKDEDE B. B., ULAŞ H., AKTENER A., CAN C., et al.
43. Ulusal Psikiyatri Kongresi, Turkey, 23 - 27 October 2007, (Summary Text)
2007
2007133. Klozapinin SHSY-5Y Nöroblastoma Hücre Hattının Çoğalmasına Etkisi
AYKAN S., AYKAN Y., BAYBOĞA M., ALPTEKİN K.
2. Ulusal Psikofarmakoloji Kongresi, Turkey, 22 - 24 June 2007, (Full Text)
2007
2007134. Increased hexosaminidase activity in psychiatric patients with drug induced extrapramidal side effects
Tunca Z., Resmi H., Ozkara A., Ciliv G., ÇELTİKÇİ B., ALPTEKİN K., et al.
62nd Annual Scientific Meeting of the Society-of-Biological-Psychiatry, California, United States Of America, 01 January 2007, vol.61, (Summary Text)
2006
2006135. The role of dopamine 2 receptor gene and personality characteristics in alcohol dependence in Turkish population
Kitis A., Akvardar Y., Eresen C., Kizildag S., Akpulat U., Yildirimcan S., et al.
19th Congress of the European-College-of-Neuropsychopharmacology, Paris, France, 16 - 20 September 2006, vol.16, (Summary Text)
2006
2006136. Patient compliance and efficacy of quetiapine treatment in schizophrenia: results of six-month follow-up study
ALPTEKİN K.
19th Congress of the European-College-of-Neuropsychopharmacology, Paris, France, 16 - 20 September 2006, vol.16, (Summary Text)
2006
2006137. Prefrontal magnetic resonance spectroscopic findings in patients with schizophrenia and their siblings
Tumuklu M., Akdede B., Men S., Karasu S., Oksuzler M., ALPTEKİN K., et al.
13th Biennial Winter Workshop on Schizophrenia Research, Davos, Switzerland, 4 - 10 February 2006, vol.81, pp.166, (Summary Text)
2006
2006138. Follow-up of patient compliance and efficacy of quetiapine treatment in schizophrenia
ALPTEKİN K.
13th Biennial Winter Workshop on Schizophrenia Research, Davos, Switzerland, 4 - 10 February 2006, vol.81, pp.76, (Summary Text)
2006
2006139. Measuring thought and language disorder in Turkish patients with schizophrenia
Ulas H., ALPTEKİN K., Ozbay D., Akdede B. B., Caki E., Tumuklu M., et al.
13th Biennial Winter Workshop on Schizophrenia Research, Davos, Switzerland, 4 - 10 February 2006, pp.286, (Summary Text)
2005
2005140. Stigmatization of schizophrenia among psychiatrists
Akdede B., Mantar A., Ozbay D., ALPTEKİN K.
20th International Congress on Schizophernia Research, Savannakhét, Laos, 2 - 06 April 2005, vol.31, pp.215, (Summary Text)
2005
2005141. Risk factors and prevalance of psychotic symptoms in the general population in Izmir-Turkey
ALPTEKİN K., Semin S., Akdede B. B., ERGÖR G., Akvardar Y., Demiral Y., et al.
20th International Congress on Schizophernia Research, Savannakhét, Laos, 2 - 06 April 2005, pp.215, (Summary Text)
2004
2004142. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine
ANIL YAĞCIOĞLU A. E., Akdede B., Turgut T., Tumuklu M., Yazici M., ALPTEKİN K., et al.
Annual Meeting of the American-College-of-Neuropsychopharmacology, San Juan, Argentina, 12 - 16 December 2004, vol.29, (Summary Text)
2004
2004143. Quality of life in patients with obsessive-compulsive disorder: Relations with cognitive functions and clinical symptoms
Akdede B., ALPTEKİN K., Akvardar Y., Kitis A.
17th Congress of the European-College-of-Neuropsychopharmacology, Stockholm, Sweden, 9 - 13 October 2004, vol.14, (Summary Text)
2004
2004144. Is substance use high among patients with schizophrenia in Turkey?
Akvardar Y., Tumuklu M., Akdede B., Ulas H., ALPTEKİN K.
17th Congress of the European-College-of-Neuropsychopharmacology, Stockholm, Sweden, 9 - 13 October 2004, vol.14, (Summary Text)
2004
2004145. Utilisation of Auditory Consonant Trigram test to screen for cognitive impairment in patients with multiple sclerosis: comparison with the Paced Auditory Serial Addition Test
Ozakbas S., Ormeci B., Akdede B., ALPTEKİN K., Idiman E., Eylul D.
20th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple- Sclerosis/9th Annual Meeting of Rehabilitation in MS, Vienna, Austria, 6 - 09 October 2004, vol.10, (Summary Text)
2004
2004146. Double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safety
Yagciolglu A., Akdede B., Turgut T., Tumuklu M., Yazici M., ALPTEKİN K., et al.
24th CINP Congress, Paris, France, 20 - 24 June 2004, vol.7, (Summary Text)
2004
2004147. Arrythmic markers affected by clozapine treatment in patients with schizophrenia:: heart rate variability, late potentials and QT dispersion
Tumuklu M., ALPTEKİN K., Kirimli O., Aslan O., Kivircik B., Badak Ö., et al.
Workshop on Neuropsychopharmacology for Young Scientific in Europe, Nice, France, 12 - 14 March 2004, vol.14, (Summary Text)
2003
2003148. The Distribution of Suicides in Turkey According to Cities and Gender
ALPTEKİN K., ÖZGÜVEN H., SAYIL I.
XXII. World Congress of the International Association for Suicide Prevention (IASP), Stockholm, Sweden, 10 - 14 September 2003, (Summary Text)
2003
2003149. Comparison of efficacy and tolerability of quetiapine and haloperidol in acute exacerbation of chronic or subchronic schizophrenia
Taneli B., ALPTEKİN K., Bilici M., Birsoz S., Eker E., Cosar B., et al.
16th Congress of the European-College-of-Neuropsychopharmacology, PRAGUE, Czech Republic, 20 - 24 September 2003, vol.13, (Summary Text)
2003
2003150. Quality of life and cognitive functions in schizophrenia
Akvardar Y., Kivircik B. B., ALPTEKİN K., Dumlu K., Isik D., PİRİNÇÇİ F., et al.
16th Congress of the European-College-of-Neuropsychopharmacology, PRAGUE, Czech Republic, 20 - 24 September 2003, (Summary Text)
2003
2003151. The distribution of suicidal behavior and risk factors in patients diagnosed with schizophrenia in a one-year multicenter follow-up study
Gogus A., ALPTEKİN K., Erkoc S., Kultur S., Mete L., Ucok A., et al.
9th International Congress on Schizophrenia Research, COLORADO SPINGS, COLORADO, 29 March - 02 April 2003, vol.60, pp.16, (Summary Text)
2003
2003152. Age related decline of severity of positive symptoms with a stable course of cognitive impairment in schizophrenia
ALPTEKİN K., Kivircik B., Kitis A., Akvardar Y.
9th International Congress on Schizophrenia Research, COLORADO SPINGS, COLORADO, 29 March - 02 April 2003, vol.60, pp.122, (Summary Text)
2003
2003153. Effect of quetiapine on cognitive functions in schizophrenia
Kvyrcyk B., ALPTEKİN K., Kiti A., Arkar H., Akvardar Y.
9th International Congress on Schizophrenia Research, COLORADO SPINGS, COLORADO, 29 March - 02 April 2003, vol.60, pp.288, (Summary Text)
2002
2002154. The Distibution of Suicidal Behaviour And Risk Factors in Patients Diagnosed With Schizophrenia in a One-Year Multicenter Follow-Up Study.
GÖĞÜŞ A. K., ALPTEKİN K., ÜÇOK V. A., YAZICI M. K.
The IXth International Congress on Schizophrenia Research., Davos, 24 February - 01 March 2002
2002
2002155. Co-Morbid Substance Abuse And Smoking in Turkish Patients With Schizophrenia.
ALPTEKİN K., GÖĞÜŞ A. K., ÜÇOK V. A., YAZICI M. K.
XIth Bennial Winter Workshop on Schizophrenia., Davos, Switzerland, 24 February - 01 March 2002
2002
2002156. A Multicenter 1- Year Follow-Up Study of Patients With Schizophrenia in Turkey: Relapse And Its Predictors.
ÜÇOK V. A., ALPTEKİN K., GÖĞÜŞ A. K., YAZICI M. K.
The XIth Bennial Winter Workshop on Schizophrenia., Davos, 24 February - 01 March 2002
2002
2002157. Relation of Family History of Schizophrenia With Clinical Variables in Patients With Schizophrenia.
ÜÇOK V. A., ALPTEKİN K., GÖĞÜŞ A. K., YAZICI M. K.
XIth Bennial Winter Workshop on Schizophrenia., Davos, Switzerland, 24 February - 01 March 2002
2002
2002158. Disability in Schizophrenia: A Multicenter Study of 1-Year Follow-Up of Patients With Schizophrenia in Turkey.
ALPTEKİN K., ÜÇOK V. A., GÖĞÜŞ A. K., YAZICI M. K.
The XIth Bennial Winter Workshop on Schizophrenia., davos, Switzerland, 24 February - 01 March 2002
2001
2001159. Türkiye’de Şizofreni Tanılı Hastalarla Yapılan Bir Yıllık Takip Çalışması.: Sosyodemografik Özelliklerin Dağılımı.
GÖĞÜŞ A. K., ALPTEKİN K.
XXXVII. Ulusal Psikiyatri Kongresi, İstanbul, Turkey, 2 - 06 October 2001
2001
2001160. Türkiye’de Şizofreni Tanılı Hastalarla Yapılan Bir Yıllık Takip Çalışması.
GÖĞÜŞ A. K., ALPTEKİN K., ÜÇOK V. A., YAZICI M. K.
XXXVIIth. Ulusal Psikiyatri Kongres, İstanbul, Turkey, 2 - 06 October 2001
2001
2001161. Şizofreniye Eşlik Eden Madde ve Sigara Kötüye Kullanımı
ALPTEKİN K., mete l., YAZICI M. K., kültür s., cirit h., ŞAYLAN İ. M.
37. Ulusal Psikiyatri Kongresi, Turkey, 4 - 06 October 2001, (Full Text)
1997
1997162. Parkinson hastaliği ve depresyon
GENÇ Ş., KIVIRCIK B. B., YENER G., ALPTEKİN K., FADILOĞLU Ş.
33. Ulusal Nöroloji Kongresi, Turkey, 24 - 28 October 1997, pp.33
1994
1994163. Lewy Cismi Tip Senil Demans Olgusu
ALPTEKİN K., YENER G.
30. Ulusal Psikiyatri Kongresİ, Turkey, 9 - 14 September 1994, pp.59
Books
2021
20211. Şizofreninin Biyokimyası (Dopamin ve Diğerleri)
KIRLI U., AKGÜL Ö., ALPTEKİN K.
in: Şizofreni ve Diğer Psikotik Bozukluklar, Esen-Danacı Ayşen, Böke Ömer, Saka Meram Can, Erol Almıla, Ulusoy Kaymak Semra, Editor, TÜRKİYE PSİKİYATRİ DERNEĞİ YAYINLARI, Ankara, pp.328-338, 2021
2021
20212. Şizofreninin Nörogelişimsel Kökenleri
KIRLI U., AKGÜL Ö., ALPTEKİN K.
in: Şizofreni ve Diğer Psikotik Bozukluklar, Esen-Danacı Ayşen, Böke Ömer, Saka Meram Can, Erol Almıla, Ulusoy Kaymak Semra, Editor, TÜRKİYE PSİKİYATRİ DERNEĞİ YAYINEVİ, Ankara, pp.319-328, 2021
2018
20183. Şizofreni ve Aile
CAN S. S., ALPTEKİN K., Aydın O., BALIKÇI K., BİNBAY İ. T., Şahin Cankurtaran E., et al.
BAYT Bilimsel Araştırmalar Basın Yayın ve Tanıtım Ltd. Şti., 2018
2018
20184. Şizofreni Etiyolojisi
CAN G., MISIR E., KÜÇÜKÇOBAN O., BİNBAY İ. T., ALPTEKİN K.
in: Temel ve Klinik Psikiyatri, Karamustafalıoğlu, Oğuz, Editor, Güneş Tıp Yayınevi, Ankara, pp.217-228, 2018
2018
20185. Ruhsal Eğitim
SEVİLMİŞ DEMİR Ş., ALPTEKİN K., BİNBAY İ. T.
in: Şizofreni ve Aile, Ulusoy Kaymak, Semra Soygür, Haldun Esen Danacı, Ayşen Alptekin, Köksal, Editor, Türkiye Psikiyatri Derneği Yayınları, Ankara, pp.49-58, 2018
2007
20076. Şizofrenide Tedaviye Direnç
ANIL YAĞCIOĞLU A. E., ÖZGÜVEN H., ALPTEKİN K.
in: Şizofreni ve Diğer Psikotik Bozukluklar, H. Soygür, K. Alptekin, E. C. Atbaşoğlu, H. Erken, Editor, Türkiye Psikiyatri Derneği Yayınları, Ankara, pp.476-499, 2007
2007
20077. Şizofreni ve Yaşam Kalitesi
SOYGÜR A. H., Özalp E., ALPTEKİN K.
in: Şizofreni ve Diğer Psikotik Bozukluklar, Soygür H, Alptekin K, Atbaşoğlu C, Herken H, Editor, Türkiye Psikiyatri Derneği Yayını, Ankara, pp.250-270, 2007
Funded Projects
2024 - 2026
2024 - 2026Şizofrenide Çevresel Koşulların Camkii İzoenzim İlişkili Bellek Sinyal Yolağına Etkisi: Beyin Dokusu Ile Periferal Kan Mononükleer Hücrelerinin İlişkisi
TUBITAK Project , 1001 - Program for Supporting Scientific and Technological Research Projects
Alptekin K., Akan P., Cilaker Mıçılı S., Yılmaz O.
2022 - 2025
2022 - 2025
Şizofreni Hastalarında Camkii Izoenzim ve Kalsiyum-Kalmodulin Sinyal Yolağı Değişimlerinin Öğrenme ve Bellek ile İlişkisi
TUBITAK Project , 1001 - Program for Supporting Scientific and Technological Research Projects
(Project Abstract)
Alptekin K. (Executive), Akan P., Akdede B. B., Keskinoğlu P.
2021 - 2024
2021 - 2024Tıp Eğitiminde Arttırılmış - Sanal Gerçeklik Uygulaması Kullanılarak Psikiyatrik Hastalıkların Daha Etkin Öğrenilmesi
Project Supported by Higher Education Institutions , BAP Research Project
KARTELLİ F. (Executive), ALPTEKİN K., Güneri S., Hoşgelen E. I., BİRANT K. U., BERGER M., et al.
2016 - 2023
2016 - 2023Şizofrenide Sanal Gerçeklik Yoluyla Sigara Bırakma Tedavisi
TUBITAK Project , 1001 - Program for Supporting Scientific and Technological Research Projects
(Project Abstract)
Alptekin K. (Executive)
2016 - 2020
2016 - 2020Nöropsikiyatrik Bozukluklarda Sanal Gerçeklik İle Bilişsel Tedavi
Project Supported by Higher Education Institutions , BAP Research Project
ALPTEKİN K., ADA E., YENER G., EMEK SAVAŞ D. D., KARTELLİ F. (Executive)
2018 - 2019
2018 - 2019Şizofrenide Motivasyonel Bozukluğun Elektrofizyolojik ve Nöropsikolojik Yöntemlerle İncelenmesi: Kilo Alımı ve Sigara Kullanımı ile İlişkisi
Project Supported by Higher Education Institutions , BAP Research Project
Alptekin K., Yener G., Bora İ. E., Akgül Ö., Emek Savaş D. D., Akdede B. B. (Executive)
2017 - 2018
2017 - 2018Uzun Etkili Enjekte Edilebilen Aripiprazolun LAI Şizofreni Hastalarında Psikososyal İşlevler Bilişsel İşlevler ve Yaşam Kalitesi Hakkında Hasta Bildirimli Tedavinin Kabul Edilebilirliği ile Nöroleptik İlaç Altında Subjektif İyilik Hali Üzerindeki Etkilerinin Değerlendirildiği Natüralistik Açık Etiketli Tek Kollu Kontrolsüz Çalışma
Company
Alptekin K. (Executive)
2014 - 2017
2014 - 2017Şizofreni Hastalarındaki Bedensel Sağlık Sorunlarını İyileştirmeye Yönelik Psiko Eğitim Programı Geliştirilmesi
Project Supported by Higher Education Institutions , BAP Research Project
ALPTEKİN K. (Executive), ÇETİNKAYA DUMAN Z.
2013 - 2016
2013 - 2016Psikoz Benzeri Yaşantı Psikotik Bozukluk İlişkisi Psikotik Bozukluğa Dönüşüm İçin Risk Faktörleri Gen Çevre Etkileşimi Toplum Tabanlı Örneklemde Bir İzlem Çalışması
TUBITAK Project
BİNBAY İ. T., ALPTEKİN K.
2013 - 2015
2013 - 2015
Diabetes Mellitusa Yatkınlık ile Psikoza Yatkınlık Arasındaki Iliskinin Incelenmesi
TUBITAK Project
ALPTEKİN K.
2007 - 2009
2007 - 2009Şizofreni ve Diğer Psikotik Bozukluklarda Gen Çevre Etkileşimi Katekol O Metiltransferaz Geni Tek Nükleotid Polimorfizmi ile Toplumsal Sermaye İlişkisinin Kentleşme Derecesine Göre İncelenmesi
TUBITAK Project
ALPTEKİN K., BİNBAY İ. T.
2007 - 2008
2007 - 2008ŞİZOFRENİDE BDNF DÜZEYİ, BİLİŞSEL ELEKTROFİZYOLOJİ VE BEYNİN YAPISAL BOZUKLUKLARI
Project Supported by Higher Education Institutions , BAP Research Project
ALPTEKİN K. (Executive)
Patent
2021
2021SANAL GERÇEKLİK YOLUYLA SİGARA BIRAKMA TEDAVİSİ
Patent
Registered / Approved, The Invention Registration Number: 2021-I-008459 , Standard Registration
Activities in Scientific Journals
2023 - Present
2023 - PresentPsychiatry and Clinical Psychopharmacology
Committee Member
2023 - Present
2023 - PresentASIAN JOURNAL OF PSYCHIATRY
Committee Member
2021 - Present
2021 - PresentALPHA PSYCHIATRY
Committee Member
Memberships and Roles in Scientific Organizations
2016 - Present
2016 - PresentSchizophrenia International Research Society
Member
2010 - Present
2010 - PresentAmerican Psychiatric Association
Member
2010 - Present
2010 - PresentEuropean College of Neuropsychopharmacology
Member
2022 - 2023
2022 - 2023European Psychiatric Association
Member
Congress and Symposium Activities
22 October 2025 - 24 October 2025
22 October 2025 - 24 October 202561.Ulusal Psikiyatri Kongresi
Panelists
Ankara-Turkey
22 October 2025 - 24 October 2025
22 October 2025 - 24 October 202561.Ulusal Psikiyatri Kongresi
Session Moderator
Ankara-Turkey
22 October 2025 - 24 October 2025
22 October 2025 - 24 October 202561. Ulusal Psikiyatri Kongresi
Panelists
Ankara-Turkey
10 October 2025 - 14 October 2025
10 October 2025 - 14 October 202538.ECNP Congress
Audience
Amsterdam-Netherlands
28 May 2025 - 31 May 2025
28 May 2025 - 31 May 202523. Ulusal Sinbirbilim Kongresi
Session Moderator
İzmir-Turkey
20 May 2025 - 22 May 2025
20 May 2025 - 22 May 2025VR-based AVATAR therapy training
Audience
Kobenhavn-Denmark
23 April 2025 - 26 April 2025
23 April 2025 - 26 April 202516th International Congress on Psychopharmacology
Panelists
Antalya-Turkey
29 March 2025 - 02 April 2025
29 March 2025 - 02 April 20252025 Annual Congress of the Scghizophrenia International Research Society
Attendee
Illinois-United States Of America
20 December 2024 - 20 December 2024
20 December 2024 - 20 December 20242.pamukkale Psikiyatri Sempozyumu
Moderator
Denizli-Turkey
20 December 2024 - 20 December 2024
20 December 2024 - 20 December 20242.Pamukkale Psikiyatri Sempozyumu
Panelists
Denizli-Turkey
30 October 2024 - 01 November 2024
30 October 2024 - 01 November 202462. Ulusal Psikiyatri Kongresi
Panelists
Antalya-Turkey
30 October 2024 - 01 November 2024
30 October 2024 - 01 November 202460. Ulusal Psikiyatri Kongresi,
Session Moderator
Antalya-Turkey
30 October 2024 - 01 November 2024
30 October 2024 - 01 November 202460.Ulusal Psikiyatri Kongresi
Panelists
Antalya-Turkey
30 October 2024 - 01 November 2024
30 October 2024 - 01 November 202460.Ulusal Psikiyatri Kongresi
Session Moderator
Antalya-Turkey
21 September 2024 - 24 September 2024
21 September 2024 - 24 September 202437.ECNP Congress
Audience
Milan-Italy
08 June 2024 - 08 June 2024
08 June 2024 - 08 June 2024Regional Medical Advisory Board for Cognitive Impairment Associated with Schizophrenia
Panelists
Dubai-United Arab Emirates
03 May 2024 - 03 May 2024
03 May 2024 - 03 May 2024Site Engagement Academy
Invited Speaker
Dubai-United Arab Emirates
22 April 2024 - 24 April 2024
22 April 2024 - 24 April 202415. Uluslararası Psikofarmakoloji Kongresi
Invited Speaker
Antalya-Turkey
03 April 2024 - 07 April 2024
03 April 2024 - 07 April 20242024 Annual Congress of the Schizophrenia International Research Society
Attendee
Florence-Italy
30 March 2023 - 01 April 2023
30 March 2023 - 01 April 2023CONNEX-I Faz III Şizofreni Çalışması
Audience
İzmir-Turkey
20 March 2023 - 22 March 2023
20 March 2023 - 22 March 2023TEVA ‘SOLARIS’ (TV44749-CNS-30096) Study Investigator Meeting
Attendee
Athens-Greece
10 November 2022 - 11 November 2022
10 November 2022 - 11 November 202213th ınternational Congress on Psychgopharmacology
Panelists
Antalya-Turkey
10 November 2022 - 12 November 2022
10 November 2022 - 12 November 202213th International Congress on Psychopharmacology
Session Moderator
Antalya-Turkey
15 October 2022 - 18 October 2022
15 October 2022 - 18 October 202236th ECNP
Audience
Vienna-Austria
06 April 2022 - 10 April 2022
06 April 2022 - 10 April 2022SIRS (Schizophrenia International Research Society) Congress 2022
Attendee
Florence-Italy
Citations
Total Citations (WOS): 3998
h-index (WOS): 28
Jury Memberships
December-2023
December 2023